SK284979B6 - Derivát tienopyrimidínu, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje - Google Patents
Derivát tienopyrimidínu, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje Download PDFInfo
- Publication number
- SK284979B6 SK284979B6 SK502-99A SK50299A SK284979B6 SK 284979 B6 SK284979 B6 SK 284979B6 SK 50299 A SK50299 A SK 50299A SK 284979 B6 SK284979 B6 SK 284979B6
- Authority
- SK
- Slovakia
- Prior art keywords
- pyrimidin
- chloro
- benzoic acid
- thieno
- pyrimidine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 11
- RBNBDIMXFJYDLQ-UHFFFAOYSA-N thieno[3,2-d]pyrimidine Chemical class C1=NC=C2SC=CC2=N1 RBNBDIMXFJYDLQ-UHFFFAOYSA-N 0.000 title claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 4
- -1 1,3- dioxolan-4-yl Chemical group 0.000 claims description 384
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims description 314
- 150000001875 compounds Chemical class 0.000 claims description 61
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 20
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 10
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 8
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 229910052801 chlorine Inorganic materials 0.000 claims description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- 150000007513 acids Chemical class 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 125000004572 morpholin-3-yl group Chemical group N1C(COCC1)* 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 125000005940 1,4-dioxanyl group Chemical group 0.000 claims description 3
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims description 3
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 claims description 3
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 3
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 claims description 3
- 238000002560 therapeutic procedure Methods 0.000 claims description 3
- 125000006730 (C2-C5) alkynyl group Chemical group 0.000 claims description 2
- OFAWUMINJWKLCV-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethylamino)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCC=2C=C3OCOC3=CC=2)=C(C2=C(CCCC2)S2)C2=N1 OFAWUMINJWKLCV-UHFFFAOYSA-N 0.000 claims description 2
- GSEIXLZVZVTEJS-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethylamino)-6-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N1=C2SC(C)=CC2=C(NCC=2C=C3OCOC3=CC=2)N=C1C1=CC=C(C(O)=O)C=C1 GSEIXLZVZVTEJS-UHFFFAOYSA-N 0.000 claims description 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 2
- 206010019280 Heart failures Diseases 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 201000001881 impotence Diseases 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- PDEQPRBUBSUBSM-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-ylmethylamino)-6-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N1=C2SC(C)=CC2=C(NCC=2C=C3OCOC3=CC=2)N=C1N1CCC(C(O)=O)CC1 PDEQPRBUBSUBSM-UHFFFAOYSA-N 0.000 claims 1
- JBUBDBSGKBJKBP-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethylamino)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1CC(C(=O)O)CCC1C1=NC(NCC=2C=C3OCOC3=CC=2)=C(C2=C(CCCC2)S2)C2=N1 JBUBDBSGKBJKBP-UHFFFAOYSA-N 0.000 claims 1
- XLPFHHGFLJMKCI-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethylamino)-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N=1C(NCC=2C=C3OCOC3=CC=2)=C2C(C)=C(C)SC2=NC=1C1=CC=C(C(O)=O)C=C1 XLPFHHGFLJMKCI-UHFFFAOYSA-N 0.000 claims 1
- NMCXWBUEDGJLDG-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethylamino)-6-chlorothieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCC=2C=C3OCOC3=CC=2)=C(C=C(Cl)S2)C2=N1 NMCXWBUEDGJLDG-UHFFFAOYSA-N 0.000 claims 1
- RIYVLKZOHQYWPV-UHFFFAOYSA-N 4-[4-[(3-chloro-4-methoxyphenyl)methylamino]-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C(CCCC1)=C1S2 RIYVLKZOHQYWPV-UHFFFAOYSA-N 0.000 claims 1
- 208000010228 Erectile Dysfunction Diseases 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 abstract description 4
- 102000011016 Type 5 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 1
- 108010037581 Type 5 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 1
- 239000005711 Benzoic acid Substances 0.000 description 163
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 147
- 235000010233 benzoic acid Nutrition 0.000 description 144
- SRJOCJYGOFTFLH-UHFFFAOYSA-N isonipecotic acid Chemical compound OC(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-N 0.000 description 85
- FPIQZBQZKBKLEI-UHFFFAOYSA-N ethyl 1-[[2-chloroethyl(nitroso)carbamoyl]amino]cyclohexane-1-carboxylate Chemical compound ClCCN(N=O)C(=O)NC1(C(=O)OCC)CCCCC1 FPIQZBQZKBKLEI-UHFFFAOYSA-N 0.000 description 76
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 62
- 150000004702 methyl esters Chemical class 0.000 description 58
- 125000004494 ethyl ester group Chemical group 0.000 description 28
- RUJPPJYDHHAEEK-UHFFFAOYSA-N ethyl piperidine-4-carboxylate Chemical compound CCOC(=O)C1CCNCC1 RUJPPJYDHHAEEK-UHFFFAOYSA-N 0.000 description 21
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 19
- 239000000243 solution Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 150000002148 esters Chemical class 0.000 description 10
- SMDKSCIOCNGNMJ-UHFFFAOYSA-N 2,4,5-trichloro-6-methylthieno[2,3-d]pyrimidine Chemical compound ClC1=NC(Cl)=C2C(Cl)=C(C)SC2=N1 SMDKSCIOCNGNMJ-UHFFFAOYSA-N 0.000 description 9
- XNAZNWXVGHIFTK-UHFFFAOYSA-N 2,4,6-trichlorothieno[2,3-d]pyrimidine Chemical compound N1=C(Cl)N=C2SC(Cl)=CC2=C1Cl XNAZNWXVGHIFTK-UHFFFAOYSA-N 0.000 description 9
- BTGNDWIMNVJZJY-UHFFFAOYSA-N 2,4-dichloro-6-methylthieno[2,3-d]pyrimidine Chemical compound N1=C(Cl)N=C2SC(C)=CC2=C1Cl BTGNDWIMNVJZJY-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- VCJCJLZVNOZZLS-UHFFFAOYSA-N [1]benzothiolo[2,3-d]pyrimidine Chemical compound C1=NC=C2C3=CC=CC=C3SC2=N1 VCJCJLZVNOZZLS-UHFFFAOYSA-N 0.000 description 8
- ICIWZNWNCSJBCO-UHFFFAOYSA-N methyl 4-(4-chloro-6-methylthieno[2,3-d]pyrimidin-2-yl)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(Cl)=C(C=C(C)S2)C2=N1 ICIWZNWNCSJBCO-UHFFFAOYSA-N 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- NZNMSOFKMUBTKW-UHFFFAOYSA-N Cyclohexanecarboxylic acid Natural products OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- OIJVRHXVISHQPS-UHFFFAOYSA-N 2,4-dichloro-5-methylthieno[2,3-d]pyrimidine Chemical compound ClC1=NC(Cl)=C2C(C)=CSC2=N1 OIJVRHXVISHQPS-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- 159000000000 sodium salts Chemical class 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- KLQGCWMIEYTEMY-UHFFFAOYSA-N methyl 4-(4,5-dichloro-6-methylthieno[2,3-d]pyrimidin-2-yl)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(Cl)=C(C(Cl)=C(C)S2)C2=N1 KLQGCWMIEYTEMY-UHFFFAOYSA-N 0.000 description 5
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 5
- CPWQCJFDDILDOU-UHFFFAOYSA-N 2,4-dichloro-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine Chemical compound C1CCCC2=C1C1=C(Cl)N=C(Cl)N=C1S2 CPWQCJFDDILDOU-UHFFFAOYSA-N 0.000 description 4
- FGZFWBZPHOEROB-UHFFFAOYSA-N 4-(4-chloro-6-ethylthieno[2,3-d]pyrimidin-2-yl)benzoic acid Chemical compound N1=C2SC(CC)=CC2=C(Cl)N=C1C1=CC=C(C(O)=O)C=C1 FGZFWBZPHOEROB-UHFFFAOYSA-N 0.000 description 4
- RSFOCWDJBLNDFF-UHFFFAOYSA-N 4-(4-chloro-6-nitrothieno[2,3-d]pyrimidin-2-yl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(Cl)=C(C=C(S2)[N+]([O-])=O)C2=N1 RSFOCWDJBLNDFF-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- DDWBRNXDKNIQDY-UHFFFAOYSA-N thieno[2,3-d]pyrimidine Chemical compound N1=CN=C2SC=CC2=C1 DDWBRNXDKNIQDY-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- FUDYRLUSXBRPIA-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxin-6-ylmethanamine Chemical compound O1CCOC2=CC(CN)=CC=C21 FUDYRLUSXBRPIA-UHFFFAOYSA-N 0.000 description 3
- JIMQJLMPZVYOFI-UHFFFAOYSA-N 2,4-dichloro-6-(trifluoromethyl)thieno[2,3-d]pyrimidine Chemical compound N1=C(Cl)N=C2SC(C(F)(F)F)=CC2=C1Cl JIMQJLMPZVYOFI-UHFFFAOYSA-N 0.000 description 3
- DANLZOIRUUHIIX-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F DANLZOIRUUHIIX-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 239000012154 double-distilled water Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- FQRUIHYITBVGTJ-UHFFFAOYSA-N methyl 4-(4,6-dichlorothieno[2,3-d]pyrimidin-2-yl)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(Cl)=C(C=C(Cl)S2)C2=N1 FQRUIHYITBVGTJ-UHFFFAOYSA-N 0.000 description 3
- SDZIRLWQAYNJAI-UHFFFAOYSA-N methyl 4-(4-chloro-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(Cl)=C(C(C)=C(C)S2)C2=N1 SDZIRLWQAYNJAI-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- IXHNFOOSLAWRBQ-UHFFFAOYSA-N (3,4-dichlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C(Cl)=C1 IXHNFOOSLAWRBQ-UHFFFAOYSA-N 0.000 description 2
- DIVNUTGTTIRPQA-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1OC DIVNUTGTTIRPQA-UHFFFAOYSA-N 0.000 description 2
- OCNMSDZALRAYEX-UHFFFAOYSA-N (3-chloro-4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1Cl OCNMSDZALRAYEX-UHFFFAOYSA-N 0.000 description 2
- CIUYJYRQKYGNQP-UHFFFAOYSA-N (3-nitrophenyl)methanamine Chemical compound NCC1=CC=CC([N+]([O-])=O)=C1 CIUYJYRQKYGNQP-UHFFFAOYSA-N 0.000 description 2
- IIFVWLUQBAIPMJ-UHFFFAOYSA-N (4-fluorophenyl)methanamine Chemical compound NCC1=CC=C(F)C=C1 IIFVWLUQBAIPMJ-UHFFFAOYSA-N 0.000 description 2
- ZILSBZLQGRBMOR-UHFFFAOYSA-N 1,3-benzodioxol-5-ylmethanamine Chemical compound NCC1=CC=C2OCOC2=C1 ZILSBZLQGRBMOR-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LKVYOLPBXKHGFY-UHFFFAOYSA-N 1-[4-[(4-fluorophenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N1=C(N2CCC(CC2)C(O)=O)N=C2SC(C)=CC2=C1NCC1=CC=C(F)C=C1 LKVYOLPBXKHGFY-UHFFFAOYSA-N 0.000 description 2
- KYWAAIKIOGUKQD-UHFFFAOYSA-N 1-[5,6-dimethyl-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12C(C)=C(C)SC2=NC(N2CCC(CC2)C(O)=O)=NC=1NCC1=CC=CC([N+]([O-])=O)=C1 KYWAAIKIOGUKQD-UHFFFAOYSA-N 0.000 description 2
- LDXCWOSUWRNYEW-UHFFFAOYSA-N 2,4-dichloro-5,6-dimethylthieno[2,3-d]pyrimidine Chemical compound ClC1=NC(Cl)=C2C(C)=C(C)SC2=N1 LDXCWOSUWRNYEW-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
- QWUNUBNTEWCGHK-UHFFFAOYSA-N 4-[4-[(3-aminophenyl)methylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C=12C(C)=CSC2=NC(C=2C=CC(=CC=2)C(O)=O)=NC=1NCC1=CC=CC(N)=C1 QWUNUBNTEWCGHK-UHFFFAOYSA-N 0.000 description 2
- MMHQAHYPQGAKKC-UHFFFAOYSA-N 4-[5-methyl-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C=12C(C)=CSC2=NC(C=2C=CC(=CC=2)C(O)=O)=NC=1NCC1=CC=CC([N+]([O-])=O)=C1 MMHQAHYPQGAKKC-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000004683 dihydrates Chemical class 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 238000010931 ester hydrolysis Methods 0.000 description 2
- 238000010265 fast atom bombardment Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- RYMPZZXTASGUKL-UHFFFAOYSA-N methyl 4-(6-methyl-4-oxo-3h-thieno[2,3-d]pyrimidin-2-yl)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C(NC1=O)=NC2=C1C=C(C)S2 RYMPZZXTASGUKL-UHFFFAOYSA-N 0.000 description 2
- OYYBJRXHPLKHLR-UHFFFAOYSA-N methyl 4-[4-chloro-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(Cl)=C(C=C(S2)C(F)(F)F)C2=N1 OYYBJRXHPLKHLR-UHFFFAOYSA-N 0.000 description 2
- VBZAPADRKXKCSK-UHFFFAOYSA-N methyl 4-[5,6-dimethyl-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCCC=2C=CC=CC=2)=C(C(C)=C(C)S2)C2=N1 VBZAPADRKXKCSK-UHFFFAOYSA-N 0.000 description 2
- KKZMIDYKRKGJHG-UHFFFAOYSA-N methyl 4-cyanobenzoate Chemical compound COC(=O)C1=CC=C(C#N)C=C1 KKZMIDYKRKGJHG-UHFFFAOYSA-N 0.000 description 2
- RRIRDPSOCUCGBV-UHFFFAOYSA-N methylenedioxyphenethylamine Chemical compound NCCC1=CC=C2OCOC2=C1 RRIRDPSOCUCGBV-UHFFFAOYSA-N 0.000 description 2
- SOCVSEIBDOAJLQ-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-2-chloro-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C2OCOC2=CC(CNC2=C3C=C(SC3=NC(Cl)=N2)C)=C1 SOCVSEIBDOAJLQ-UHFFFAOYSA-N 0.000 description 2
- BJAUWDNYSRMCDJ-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-amine Chemical compound C1=C2OCOC2=CC(CNC=2C=3C=4CCCCC=4SC=3N=CN=2)=C1 BJAUWDNYSRMCDJ-UHFFFAOYSA-N 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 description 1
- VWVZFHRDLPHBEG-UHFFFAOYSA-N 1-(chloromethyl)-4-methylsulfanylbenzene Chemical group CSC1=CC=C(CCl)C=C1 VWVZFHRDLPHBEG-UHFFFAOYSA-N 0.000 description 1
- OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 description 1
- ZRLGNOUOXZKMAF-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-ylmethylamino)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C3OCOC3=CC=2)=C(C2=C(CCCC2)S2)C2=N1 ZRLGNOUOXZKMAF-UHFFFAOYSA-N 0.000 description 1
- KMDVGVWQIMBNBM-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-ylmethylamino)-5-chloro-6-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N=1C(NCC=2C=C3OCOC3=CC=2)=C2C(Cl)=C(C)SC2=NC=1N1CCC(C(O)=O)CC1 KMDVGVWQIMBNBM-UHFFFAOYSA-N 0.000 description 1
- LKSWXOSDQWCTMB-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-ylmethylamino)-5-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N=1C(NCC=2C=C3OCOC3=CC=2)=C2C(C)=CSC2=NC=1N1CCC(C(O)=O)CC1 LKSWXOSDQWCTMB-UHFFFAOYSA-N 0.000 description 1
- CXKVCAVVUJUESH-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-ylmethylamino)-6-chlorothieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C3OCOC3=CC=2)=C(C=C(Cl)S2)C2=N1 CXKVCAVVUJUESH-UHFFFAOYSA-N 0.000 description 1
- KIUQDLNHTOVSKB-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-ylmethylamino)-6-ethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N1=C2SC(CC)=CC2=C(NCC=2C=C3OCOC3=CC=2)N=C1N1CCC(C(O)=O)CC1 KIUQDLNHTOVSKB-UHFFFAOYSA-N 0.000 description 1
- XTTAYOIJLJDNBU-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-ylmethylamino)-6-nitrothieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C3OCOC3=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 XTTAYOIJLJDNBU-UHFFFAOYSA-N 0.000 description 1
- KOWPKBZDENFEIY-UHFFFAOYSA-N 1-[4-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N=1C(NCC=2C=C3OCCOC3=CC=2)=C2C(C)=C(C)SC2=NC=1N1CCC(C(O)=O)CC1 KOWPKBZDENFEIY-UHFFFAOYSA-N 0.000 description 1
- AGCFWRVCQIXMQY-UHFFFAOYSA-N 1-[4-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)-5-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N=1C(NCC=2C=C3OCCOC3=CC=2)=C2C(C)=CSC2=NC=1N1CCC(C(O)=O)CC1 AGCFWRVCQIXMQY-UHFFFAOYSA-N 0.000 description 1
- IHVZGAOYLPUAQP-UHFFFAOYSA-N 1-[4-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C3OCCOC3=CC=2)=C(C=C(S2)C(F)(F)F)C2=N1 IHVZGAOYLPUAQP-UHFFFAOYSA-N 0.000 description 1
- JAMVWJJOAGAAAX-UHFFFAOYSA-N 1-[4-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)-6-ethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N1=C2SC(CC)=CC2=C(NCC=2C=C3OCCOC3=CC=2)N=C1N1CCC(C(O)=O)CC1 JAMVWJJOAGAAAX-UHFFFAOYSA-N 0.000 description 1
- HVFJQTCAJIMGON-UHFFFAOYSA-N 1-[4-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)-6-nitrothieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C3OCCOC3=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 HVFJQTCAJIMGON-UHFFFAOYSA-N 0.000 description 1
- LDPXNEZBDJCOSM-UHFFFAOYSA-N 1-[4-(benzylamino)-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12C(C)=C(C)SC2=NC(N2CCC(CC2)C(O)=O)=NC=1NCC1=CC=CC=C1 LDPXNEZBDJCOSM-UHFFFAOYSA-N 0.000 description 1
- LPRBAGNJZULBPD-UHFFFAOYSA-N 1-[4-(benzylamino)-5-chloro-6-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12C(Cl)=C(C)SC2=NC(N2CCC(CC2)C(O)=O)=NC=1NCC1=CC=CC=C1 LPRBAGNJZULBPD-UHFFFAOYSA-N 0.000 description 1
- KUJFDVTYNAEUFA-UHFFFAOYSA-N 1-[4-(benzylamino)-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=CC=CC=2)=C(C=C(S2)C(F)(F)F)C2=N1 KUJFDVTYNAEUFA-UHFFFAOYSA-N 0.000 description 1
- ZKJZJNFDBRFCEV-UHFFFAOYSA-N 1-[4-(benzylamino)-6-nitrothieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=CC=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 ZKJZJNFDBRFCEV-UHFFFAOYSA-N 0.000 description 1
- LVWVNWTWUIDKBD-UHFFFAOYSA-N 1-[4-[(3,4-dichlorophenyl)methylamino]-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C(Cl)C(Cl)=CC=2)=C(C=C(S2)C(F)(F)F)C2=N1 LVWVNWTWUIDKBD-UHFFFAOYSA-N 0.000 description 1
- WPLPLUROCIKCMR-UHFFFAOYSA-N 1-[4-[(3,4-dichlorophenyl)methylamino]-6-ethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N1=C(N2CCC(CC2)C(O)=O)N=C2SC(CC)=CC2=C1NCC1=CC=C(Cl)C(Cl)=C1 WPLPLUROCIKCMR-UHFFFAOYSA-N 0.000 description 1
- RHRVOYUAGVANMJ-UHFFFAOYSA-N 1-[4-[(3,4-dichlorophenyl)methylamino]-6-nitrothieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C(Cl)C(Cl)=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 RHRVOYUAGVANMJ-UHFFFAOYSA-N 0.000 description 1
- ZPCGBOZJZAUVKD-UHFFFAOYSA-N 1-[4-[(3,4-dimethoxyphenyl)methylamino]-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(N2CCC(CC2)C(O)=O)=NC2=C1C(CCCC1)=C1S2 ZPCGBOZJZAUVKD-UHFFFAOYSA-N 0.000 description 1
- ZZRBNPLPTGSNOP-UHFFFAOYSA-N 1-[4-[(3,4-dimethoxyphenyl)methylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(N2CCC(CC2)C(O)=O)=NC2=C1C(C)=C(C)S2 ZZRBNPLPTGSNOP-UHFFFAOYSA-N 0.000 description 1
- WKZAAVZMZYTEJB-UHFFFAOYSA-N 1-[4-[(3,4-dimethoxyphenyl)methylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(N2CCC(CC2)C(O)=O)=NC2=C1C(C)=CS2 WKZAAVZMZYTEJB-UHFFFAOYSA-N 0.000 description 1
- WLRISXUAMLEHID-UHFFFAOYSA-N 1-[4-[(3,4-dimethoxyphenyl)methylamino]-6-ethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N1=C(N2CCC(CC2)C(O)=O)N=C2SC(CC)=CC2=C1NCC1=CC=C(OC)C(OC)=C1 WLRISXUAMLEHID-UHFFFAOYSA-N 0.000 description 1
- YUDDPANPKXLRGY-UHFFFAOYSA-N 1-[4-[(3,4-dimethoxyphenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(N2CCC(CC2)C(O)=O)=NC2=C1C=C(C)S2 YUDDPANPKXLRGY-UHFFFAOYSA-N 0.000 description 1
- UGBOWKPJOZLUMH-UHFFFAOYSA-N 1-[4-[(3-chloro-4-methoxyphenyl)methylamino]-6-ethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N1=C(N2CCC(CC2)C(O)=O)N=C2SC(CC)=CC2=C1NCC1=CC=C(OC)C(Cl)=C1 UGBOWKPJOZLUMH-UHFFFAOYSA-N 0.000 description 1
- ROIKORQGPAKDPS-UHFFFAOYSA-N 1-[4-[(3-nitrophenyl)methylamino]-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C(C=CC=2)[N+]([O-])=O)=C(C=C(S2)C(F)(F)F)C2=N1 ROIKORQGPAKDPS-UHFFFAOYSA-N 0.000 description 1
- LLXLBVFFJSNGOK-UHFFFAOYSA-N 1-[4-[(4-fluorophenyl)methylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12C(C)=C(C)SC2=NC(N2CCC(CC2)C(O)=O)=NC=1NCC1=CC=C(F)C=C1 LLXLBVFFJSNGOK-UHFFFAOYSA-N 0.000 description 1
- JCMKPRCJWCVUDU-UHFFFAOYSA-N 1-[4-[(4-fluorophenyl)methylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12C(C)=CSC2=NC(N2CCC(CC2)C(O)=O)=NC=1NCC1=CC=C(F)C=C1 JCMKPRCJWCVUDU-UHFFFAOYSA-N 0.000 description 1
- VBGRNHLDSNXDLN-UHFFFAOYSA-N 1-[4-[(4-fluorophenyl)methylamino]-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=CC(F)=CC=2)=C(C=C(S2)C(F)(F)F)C2=N1 VBGRNHLDSNXDLN-UHFFFAOYSA-N 0.000 description 1
- MUKJEFUQEQZFGN-UHFFFAOYSA-N 1-[4-[(4-fluorophenyl)methylamino]-6-nitrothieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=CC(F)=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 MUKJEFUQEQZFGN-UHFFFAOYSA-N 0.000 description 1
- HFCQIJYTXWVEAX-UHFFFAOYSA-N 1-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCCC=2C=C3OCOC3=CC=2)=C(C2=C(CCCC2)S2)C2=N1 HFCQIJYTXWVEAX-UHFFFAOYSA-N 0.000 description 1
- LGYANGCCZHOQMI-UHFFFAOYSA-N 1-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N=1C(NCCC=2C=C3OCOC3=CC=2)=C2C(C)=C(C)SC2=NC=1N1CCC(C(O)=O)CC1 LGYANGCCZHOQMI-UHFFFAOYSA-N 0.000 description 1
- NABXFRAQDAVUFQ-UHFFFAOYSA-N 1-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-5-chloro-6-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N=1C(NCCC=2C=C3OCOC3=CC=2)=C2C(Cl)=C(C)SC2=NC=1N1CCC(C(O)=O)CC1 NABXFRAQDAVUFQ-UHFFFAOYSA-N 0.000 description 1
- BEKVBGCZGDQPJE-UHFFFAOYSA-N 1-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N=1C(NCCC=2C=C3OCOC3=CC=2)=C2C(C)=CSC2=NC=1N1CCC(C(O)=O)CC1 BEKVBGCZGDQPJE-UHFFFAOYSA-N 0.000 description 1
- RXUNWHURWVRVKH-UHFFFAOYSA-N 1-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCCC=2C=C3OCOC3=CC=2)=C(C=C(S2)C(F)(F)F)C2=N1 RXUNWHURWVRVKH-UHFFFAOYSA-N 0.000 description 1
- PMOFFRUTMAFHLY-UHFFFAOYSA-N 1-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-6-chlorothieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCCC=2C=C3OCOC3=CC=2)=C(C=C(Cl)S2)C2=N1 PMOFFRUTMAFHLY-UHFFFAOYSA-N 0.000 description 1
- HRLYDZIGBJVICZ-UHFFFAOYSA-N 1-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-6-ethylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N1=C2SC(CC)=CC2=C(NCCC=2C=C3OCOC3=CC=2)N=C1N1CCC(C(O)=O)CC1 HRLYDZIGBJVICZ-UHFFFAOYSA-N 0.000 description 1
- PTXFPGHSGUAYNL-UHFFFAOYSA-N 1-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-6-nitrothieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCCC=2C=C3OCOC3=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 PTXFPGHSGUAYNL-UHFFFAOYSA-N 0.000 description 1
- DSEHDOCOHHSQIF-UHFFFAOYSA-N 1-[5-chloro-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)-6-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N=1C(NCC=2C=C3OCCOC3=CC=2)=C2C(Cl)=C(C)SC2=NC=1N1CCC(C(O)=O)CC1 DSEHDOCOHHSQIF-UHFFFAOYSA-N 0.000 description 1
- MSKJXYJVINTYPF-UHFFFAOYSA-N 1-[5-chloro-4-[(3,4-dichlorophenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12C(Cl)=C(C)SC2=NC(N2CCC(CC2)C(O)=O)=NC=1NCC1=CC=C(Cl)C(Cl)=C1 MSKJXYJVINTYPF-UHFFFAOYSA-N 0.000 description 1
- KKVYLUNRDWDFFO-UHFFFAOYSA-N 1-[5-chloro-4-[(3-chloro-4-methoxyphenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(N2CCC(CC2)C(O)=O)=NC2=C1C(Cl)=C(C)S2 KKVYLUNRDWDFFO-UHFFFAOYSA-N 0.000 description 1
- HQVDKKPWXRFKSE-UHFFFAOYSA-N 1-[6-chloro-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C3OCCOC3=CC=2)=C(C=C(Cl)S2)C2=N1 HQVDKKPWXRFKSE-UHFFFAOYSA-N 0.000 description 1
- KHJQJSCAGYFUNI-UHFFFAOYSA-N 1-[6-chloro-4-[(3,4-dichlorophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C(Cl)C(Cl)=CC=2)=C(C=C(Cl)S2)C2=N1 KHJQJSCAGYFUNI-UHFFFAOYSA-N 0.000 description 1
- XJWDEXYVYJQXCR-UHFFFAOYSA-N 1-[6-chloro-4-[(3-chloro-4-methoxyphenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(N2CCC(CC2)C(O)=O)=NC2=C1C=C(Cl)S2 XJWDEXYVYJQXCR-UHFFFAOYSA-N 0.000 description 1
- PFMMYLSSNKSZGP-UHFFFAOYSA-N 1-[6-methyl-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound N1=C(N2CCC(CC2)C(O)=O)N=C2SC(C)=CC2=C1NCC1=CC=CC([N+]([O-])=O)=C1 PFMMYLSSNKSZGP-UHFFFAOYSA-N 0.000 description 1
- NFWMDPFHXTUMPJ-UHFFFAOYSA-N 1-[6-nitro-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC(NCC=2C=C(C=CC=2)[N+]([O-])=O)=C(C=C(S2)[N+]([O-])=O)C2=N1 NFWMDPFHXTUMPJ-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- RIZUCYSQUWMQLX-UHFFFAOYSA-N 2,3-dimethylbenzoic acid Chemical compound CC1=CC=CC(C(O)=O)=C1C RIZUCYSQUWMQLX-UHFFFAOYSA-N 0.000 description 1
- BCHQHHYTBVURCM-UHFFFAOYSA-N 2,4-dichloro-6-nitrothieno[2,3-d]pyrimidine Chemical compound N1=C(Cl)N=C2SC([N+](=O)[O-])=CC2=C1Cl BCHQHHYTBVURCM-UHFFFAOYSA-N 0.000 description 1
- ROZGXPGWGKUTAT-UHFFFAOYSA-N 2,5-dichloro-6-methyl-n-[(3-nitrophenyl)methyl]thieno[2,3-d]pyrimidin-4-amine Chemical compound C=12C(Cl)=C(C)SC2=NC(Cl)=NC=1NCC1=CC=CC([N+]([O-])=O)=C1 ROZGXPGWGKUTAT-UHFFFAOYSA-N 0.000 description 1
- HENBXUORNVCDNN-UHFFFAOYSA-N 2,5-dichloro-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound O1CCOC2=CC(CNC=3N=C(Cl)N=C4SC(=C(C4=3)Cl)C)=CC=C21 HENBXUORNVCDNN-UHFFFAOYSA-N 0.000 description 1
- QEFZBFDQBOZHLO-UHFFFAOYSA-N 2,5-dichloro-n-[(3,4-dichlorophenyl)methyl]-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C=12C(Cl)=C(C)SC2=NC(Cl)=NC=1NCC1=CC=C(Cl)C(Cl)=C1 QEFZBFDQBOZHLO-UHFFFAOYSA-N 0.000 description 1
- JHUPVGRBKUASFC-UHFFFAOYSA-N 2,5-dichloro-n-[(3,4-dimethoxyphenyl)methyl]-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(Cl)=NC2=C1C(Cl)=C(C)S2 JHUPVGRBKUASFC-UHFFFAOYSA-N 0.000 description 1
- REXFFBYLEMUYMD-UHFFFAOYSA-N 2,5-dichloro-n-[(3-chloro-4-methoxyphenyl)methyl]-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(Cl)=NC2=C1C(Cl)=C(C)S2 REXFFBYLEMUYMD-UHFFFAOYSA-N 0.000 description 1
- KSUREKBPOVWBMD-UHFFFAOYSA-N 2,5-dichloro-n-[(4-fluorophenyl)methyl]-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C=12C(Cl)=C(C)SC2=NC(Cl)=NC=1NCC1=CC=C(F)C=C1 KSUREKBPOVWBMD-UHFFFAOYSA-N 0.000 description 1
- AUDIQNAYRVRUBV-UHFFFAOYSA-N 2,6-dichloro-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)thieno[2,3-d]pyrimidin-4-amine Chemical compound O1CCOC2=CC(CNC3=C4C=C(SC4=NC(Cl)=N3)Cl)=CC=C21 AUDIQNAYRVRUBV-UHFFFAOYSA-N 0.000 description 1
- FIQOJQQDNPVKHY-UHFFFAOYSA-N 2,6-dichloro-n-[(3,4-dichlorophenyl)methyl]thieno[2,3-d]pyrimidin-4-amine Chemical compound N1=C(Cl)N=C2SC(Cl)=CC2=C1NCC1=CC=C(Cl)C(Cl)=C1 FIQOJQQDNPVKHY-UHFFFAOYSA-N 0.000 description 1
- OYYPIQNIYLXVAB-UHFFFAOYSA-N 2,6-dichloro-n-[(3,4-dimethoxyphenyl)methyl]thieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(Cl)=NC2=C1C=C(Cl)S2 OYYPIQNIYLXVAB-UHFFFAOYSA-N 0.000 description 1
- JTBMXHSWVWRJPQ-UHFFFAOYSA-N 2,6-dichloro-n-[(3-chloro-4-methoxyphenyl)methyl]thieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(Cl)=NC2=C1C=C(Cl)S2 JTBMXHSWVWRJPQ-UHFFFAOYSA-N 0.000 description 1
- KECAIPKIPYBBOH-UHFFFAOYSA-N 2,6-dichloro-n-[(3-nitrophenyl)methyl]thieno[2,3-d]pyrimidin-4-amine Chemical compound [O-][N+](=O)C1=CC=CC(CNC=2C=3C=C(Cl)SC=3N=C(Cl)N=2)=C1 KECAIPKIPYBBOH-UHFFFAOYSA-N 0.000 description 1
- YLJFKKPREKVKAX-UHFFFAOYSA-N 2,6-dichloro-n-[(4-fluorophenyl)methyl]thieno[2,3-d]pyrimidin-4-amine Chemical compound C1=CC(F)=CC=C1CNC1=NC(Cl)=NC2=C1C=C(Cl)S2 YLJFKKPREKVKAX-UHFFFAOYSA-N 0.000 description 1
- LVYFSENHOZHUKT-UHFFFAOYSA-N 2-chloro-5-methyl-n-[(3-nitrophenyl)methyl]thieno[2,3-d]pyrimidin-4-amine Chemical compound C=12C(C)=CSC2=NC(Cl)=NC=1NCC1=CC=CC([N+]([O-])=O)=C1 LVYFSENHOZHUKT-UHFFFAOYSA-N 0.000 description 1
- QHRSYAMUAAJCRK-UHFFFAOYSA-N 2-chloro-6-ethyl-n-[(3-nitrophenyl)methyl]thieno[2,3-d]pyrimidin-4-amine;2,4-dichloro-6-ethylthieno[2,3-d]pyrimidine Chemical compound N1=C(Cl)N=C2SC(CC)=CC2=C1Cl.N1=C(Cl)N=C2SC(CC)=CC2=C1NCC1=CC=CC([N+]([O-])=O)=C1 QHRSYAMUAAJCRK-UHFFFAOYSA-N 0.000 description 1
- UNJLRVOFIPLDSA-UHFFFAOYSA-N 2-chloro-6-ethyl-n-[(4-fluorophenyl)methyl]thieno[2,3-d]pyrimidin-4-amine Chemical compound N1=C(Cl)N=C2SC(CC)=CC2=C1NCC1=CC=C(F)C=C1 UNJLRVOFIPLDSA-UHFFFAOYSA-N 0.000 description 1
- WXOFXEJWAXCLRY-UHFFFAOYSA-N 2-chloro-6-methyl-n-[(3-nitrophenyl)methyl]thieno[2,3-d]pyrimidin-4-amine Chemical compound N1=C(Cl)N=C2SC(C)=CC2=C1NCC1=CC=CC([N+]([O-])=O)=C1 WXOFXEJWAXCLRY-UHFFFAOYSA-N 0.000 description 1
- UVBLCUMJRXUGAY-UHFFFAOYSA-N 2-chloro-N-[(3,4-dimethoxyphenyl)methyl]-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-amine 2,4-dichloro-6-(trifluoromethyl)thieno[2,3-d]pyrimidine Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)C(F)(F)F)NCC2=CC(=C(C=C2)OC)OC.ClC=2N=C(C1=C(N2)SC(=C1)C(F)(F)F)Cl UVBLCUMJRXUGAY-UHFFFAOYSA-N 0.000 description 1
- XXNJVGSVZUIMBJ-UHFFFAOYSA-N 2-chloro-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-amine Chemical compound C1CCCC2=C1C1=C(NCC=3C=C4OCCOC4=CC=3)N=C(Cl)N=C1S2 XXNJVGSVZUIMBJ-UHFFFAOYSA-N 0.000 description 1
- ZDOVFZZVMIPTMQ-UHFFFAOYSA-N 2-chloro-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine Chemical compound O1CCOC2=CC(CNC=3N=C(Cl)N=C4SC(=C(C4=3)C)C)=CC=C21 ZDOVFZZVMIPTMQ-UHFFFAOYSA-N 0.000 description 1
- IQTHGWRJYPJNEB-UHFFFAOYSA-N 2-chloro-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-ethylthieno[2,3-d]pyrimidin-4-amine Chemical compound O1CCOC2=CC(CNC3=C4C=C(SC4=NC(Cl)=N3)CC)=CC=C21 IQTHGWRJYPJNEB-UHFFFAOYSA-N 0.000 description 1
- XZOZIWFGZMXPEA-UHFFFAOYSA-N 2-chloro-n-[(3,4-dichlorophenyl)methyl]-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-amine Chemical compound C=12C=3CCCCC=3SC2=NC(Cl)=NC=1NCC1=CC=C(Cl)C(Cl)=C1 XZOZIWFGZMXPEA-UHFFFAOYSA-N 0.000 description 1
- XLPQIUHAVFMIFU-UHFFFAOYSA-N 2-chloro-n-[(3,4-dichlorophenyl)methyl]-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine;2,4-dichloro-5,6-dimethylthieno[2,3-d]pyrimidine Chemical compound ClC1=NC(Cl)=C2C(C)=C(C)SC2=N1.C=12C(C)=C(C)SC2=NC(Cl)=NC=1NCC1=CC=C(Cl)C(Cl)=C1 XLPQIUHAVFMIFU-UHFFFAOYSA-N 0.000 description 1
- CNIAXPQTVQONMY-UHFFFAOYSA-N 2-chloro-n-[(3,4-dichlorophenyl)methyl]-5-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C=12C(C)=CSC2=NC(Cl)=NC=1NCC1=CC=C(Cl)C(Cl)=C1 CNIAXPQTVQONMY-UHFFFAOYSA-N 0.000 description 1
- DNHFVWKOJSMAEF-UHFFFAOYSA-N 2-chloro-n-[(3,4-dichlorophenyl)methyl]-6-ethylthieno[2,3-d]pyrimidin-4-amine Chemical compound N1=C(Cl)N=C2SC(CC)=CC2=C1NCC1=CC=C(Cl)C(Cl)=C1 DNHFVWKOJSMAEF-UHFFFAOYSA-N 0.000 description 1
- MAWFDQDICIFDQX-UHFFFAOYSA-N 2-chloro-n-[(3,4-dichlorophenyl)methyl]-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound N1=C(Cl)N=C2SC(C)=CC2=C1NCC1=CC=C(Cl)C(Cl)=C1 MAWFDQDICIFDQX-UHFFFAOYSA-N 0.000 description 1
- GPAMIDREOBUWKV-UHFFFAOYSA-N 2-chloro-n-[(3,4-dichlorophenyl)methyl]-6-nitrothieno[2,3-d]pyrimidin-4-amine Chemical compound N1=C(Cl)N=C2SC([N+](=O)[O-])=CC2=C1NCC1=CC=C(Cl)C(Cl)=C1 GPAMIDREOBUWKV-UHFFFAOYSA-N 0.000 description 1
- GEBLHLXLUBDZNV-UHFFFAOYSA-N 2-chloro-n-[(3,4-dimethoxyphenyl)methyl]-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(Cl)=NC2=C1C(C)=C(C)S2 GEBLHLXLUBDZNV-UHFFFAOYSA-N 0.000 description 1
- XUUPTPFNSBQMIC-UHFFFAOYSA-N 2-chloro-n-[(3-chloro-4-methoxyphenyl)methyl]-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(Cl)=NC2=C1C(C)=C(C)S2 XUUPTPFNSBQMIC-UHFFFAOYSA-N 0.000 description 1
- NEUFJJNSHFZKOH-UHFFFAOYSA-N 2-chloro-n-[(3-chloro-4-methoxyphenyl)methyl]-5-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(Cl)=NC2=C1C(C)=CS2 NEUFJJNSHFZKOH-UHFFFAOYSA-N 0.000 description 1
- MRQDTFIOOGROBF-UHFFFAOYSA-N 2-chloro-n-[(3-chloro-4-methoxyphenyl)methyl]-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(Cl)=NC2=C1C=C(C(F)(F)F)S2 MRQDTFIOOGROBF-UHFFFAOYSA-N 0.000 description 1
- MKIFCAUJKZKILI-UHFFFAOYSA-N 2-chloro-n-[(3-chloro-4-methoxyphenyl)methyl]-6-nitrothieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(Cl)=NC2=C1C=C([N+]([O-])=O)S2 MKIFCAUJKZKILI-UHFFFAOYSA-N 0.000 description 1
- XLIRKTUUFBJAPV-UHFFFAOYSA-N 2-chloro-n-[(3-nitrophenyl)methyl]-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-amine Chemical compound [O-][N+](=O)C1=CC=CC(CNC=2C=3C=4CCCCC=4SC=3N=C(Cl)N=2)=C1 XLIRKTUUFBJAPV-UHFFFAOYSA-N 0.000 description 1
- VNCAJECFTKQVLU-UHFFFAOYSA-N 2-chloro-n-[(4-fluorophenyl)methyl]-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-amine Chemical compound C1=CC(F)=CC=C1CNC1=NC(Cl)=NC2=C1C(CCCC1)=C1S2 VNCAJECFTKQVLU-UHFFFAOYSA-N 0.000 description 1
- WTELHNYLMSLRRK-UHFFFAOYSA-N 2-chloro-n-[(4-fluorophenyl)methyl]-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine;2,4-dichloro-5,6-dimethylthieno[2,3-d]pyrimidine Chemical compound ClC1=NC(Cl)=C2C(C)=C(C)SC2=N1.C=12C(C)=C(C)SC2=NC(Cl)=NC=1NCC1=CC=C(F)C=C1 WTELHNYLMSLRRK-UHFFFAOYSA-N 0.000 description 1
- KDWDJVXPLBEMRH-UHFFFAOYSA-N 2-chloro-n-[(4-fluorophenyl)methyl]-6-nitrothieno[2,3-d]pyrimidin-4-amine;2,4-dichloro-6-nitrothieno[2,3-d]pyrimidine Chemical compound N1=C(Cl)N=C2SC([N+](=O)[O-])=CC2=C1Cl.N1=C(Cl)N=C2SC([N+](=O)[O-])=CC2=C1NCC1=CC=C(F)C=C1 KDWDJVXPLBEMRH-UHFFFAOYSA-N 0.000 description 1
- VTTHDZKNPJZPEM-UHFFFAOYSA-N 2-chlorothieno[2,3-d]pyrimidine Chemical class ClC1=NC=C2C=CSC2=N1 VTTHDZKNPJZPEM-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- BCLGTIBYZQQFJW-UHFFFAOYSA-N 2-pyrimidin-2-ylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1=NC=CC=N1 BCLGTIBYZQQFJW-UHFFFAOYSA-N 0.000 description 1
- 102000001707 3',5'-Cyclic-AMP Phosphodiesterases Human genes 0.000 description 1
- 108010054479 3',5'-Cyclic-AMP Phosphodiesterases Proteins 0.000 description 1
- UBCBXXBQMBDYPT-UHFFFAOYSA-N 4-(4,6-dichlorothieno[2,3-d]pyrimidin-2-yl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(Cl)=C(C=C(Cl)S2)C2=N1 UBCBXXBQMBDYPT-UHFFFAOYSA-N 0.000 description 1
- QROZKHPQMUXRGA-UHFFFAOYSA-N 4-(4-chloro-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl)benzoic acid Chemical compound N=1C(Cl)=C2C(C)=C(C)SC2=NC=1C1=CC=C(C(O)=O)C=C1 QROZKHPQMUXRGA-UHFFFAOYSA-N 0.000 description 1
- SKRBONVMXKJJCY-UHFFFAOYSA-N 4-(4-chloro-6-methylthieno[2,3-d]pyrimidin-2-yl)benzoic acid Chemical compound N1=C2SC(C)=CC2=C(Cl)N=C1C1=CC=C(C(O)=O)C=C1 SKRBONVMXKJJCY-UHFFFAOYSA-N 0.000 description 1
- NQHUHEZEEREEDS-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethylamino)-5-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1OC=2C=C(CNC=3C4=C(N=C(N=3)C3=CC=C(C(=O)O)C=C3)SC=C4C)C=CC=2O1 NQHUHEZEEREEDS-UHFFFAOYSA-N 0.000 description 1
- WJVAACHFRBXFQP-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethylamino)-6-ethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N1=C2SC(CC)=CC2=C(NCC=2C=C3OCOC3=CC=2)N=C1C1=CC=C(C(O)=O)C=C1 WJVAACHFRBXFQP-UHFFFAOYSA-N 0.000 description 1
- POJBRPAMNJQGCJ-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethylamino)-6-nitrothieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCC=2C=C3OCOC3=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 POJBRPAMNJQGCJ-UHFFFAOYSA-N 0.000 description 1
- XMTIQVYWNBLHQS-UHFFFAOYSA-N 4-[4-(2-phenylethylamino)-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1CC(C(=O)O)CCC1C1=NC(NCCC=2C=CC=CC=2)=C(C=C(S2)C(F)(F)F)C2=N1 XMTIQVYWNBLHQS-UHFFFAOYSA-N 0.000 description 1
- DQMCHVIWWXHMHP-UHFFFAOYSA-N 4-[4-(benzylamino)-6-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N1=C(C=2C=CC(=CC=2)C(O)=O)N=C2SC(C)=CC2=C1NCC1=CC=CC=C1 DQMCHVIWWXHMHP-UHFFFAOYSA-N 0.000 description 1
- BUAAOZHTTWXTFT-UHFFFAOYSA-N 4-[4-[(3,4-dichlorophenyl)methylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C=12C(C)=C(C)SC2=NC(C=2C=CC(=CC=2)C(O)=O)=NC=1NCC1=CC=C(Cl)C(Cl)=C1 BUAAOZHTTWXTFT-UHFFFAOYSA-N 0.000 description 1
- DMAXUZAXYBIPKL-UHFFFAOYSA-N 4-[4-[(3,4-dichlorophenyl)methylamino]-6-ethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N1=C(C=2C=CC(=CC=2)C(O)=O)N=C2SC(CC)=CC2=C1NCC1=CC=C(Cl)C(Cl)=C1 DMAXUZAXYBIPKL-UHFFFAOYSA-N 0.000 description 1
- UBYLWGQVSYYGEA-UHFFFAOYSA-N 4-[4-[(3,4-dichlorophenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N1=C(C=2C=CC(=CC=2)C(O)=O)N=C2SC(C)=CC2=C1NCC1=CC=C(Cl)C(Cl)=C1 UBYLWGQVSYYGEA-UHFFFAOYSA-N 0.000 description 1
- LIIPXQIAKAUEFO-UHFFFAOYSA-N 4-[4-[(3,4-dimethoxyphenyl)methylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C(C)=C(C)S2 LIIPXQIAKAUEFO-UHFFFAOYSA-N 0.000 description 1
- WROQKJQMWGOELV-UHFFFAOYSA-N 4-[4-[(3,4-dimethoxyphenyl)methylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C(C)=C(C)S2 WROQKJQMWGOELV-UHFFFAOYSA-N 0.000 description 1
- IJEOEWRSCVJLHE-UHFFFAOYSA-N 4-[4-[(3,4-dimethoxyphenyl)methylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C(C)=CS2 IJEOEWRSCVJLHE-UHFFFAOYSA-N 0.000 description 1
- QWAVXMNTGROLGX-UHFFFAOYSA-N 4-[4-[(3,4-dimethoxyphenyl)methylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C(C)=CS2 QWAVXMNTGROLGX-UHFFFAOYSA-N 0.000 description 1
- IPWFXNRLLUSXHJ-UHFFFAOYSA-N 4-[4-[(3,4-dimethoxyphenyl)methylamino]-6-ethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N1=C(C=2C=CC(=CC=2)C(O)=O)N=C2SC(CC)=CC2=C1NCC1=CC=C(OC)C(OC)=C1 IPWFXNRLLUSXHJ-UHFFFAOYSA-N 0.000 description 1
- KTFFJWGFZAGWHX-UHFFFAOYSA-N 4-[4-[(3,4-dimethoxyphenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C=C(C)S2 KTFFJWGFZAGWHX-UHFFFAOYSA-N 0.000 description 1
- WIEWSVIJYOKGKJ-UHFFFAOYSA-N 4-[4-[(3,4-dimethoxyphenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C=C(C)S2 WIEWSVIJYOKGKJ-UHFFFAOYSA-N 0.000 description 1
- IQCLBDCSEVHUEQ-UHFFFAOYSA-N 4-[4-[(3,4-dimethoxyphenyl)methylamino]-6-nitrothieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C=C([N+]([O-])=O)S2 IQCLBDCSEVHUEQ-UHFFFAOYSA-N 0.000 description 1
- GMRFPMMNCLGXBI-UHFFFAOYSA-N 4-[4-[(3-chloro-4-methoxyphenyl)methylamino]-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C(CCCC1)=C1S2 GMRFPMMNCLGXBI-UHFFFAOYSA-N 0.000 description 1
- IOEOYZDAZQWNKY-UHFFFAOYSA-N 4-[4-[(3-chloro-4-methoxyphenyl)methylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C(C)=C(C)S2 IOEOYZDAZQWNKY-UHFFFAOYSA-N 0.000 description 1
- SYHOUTHLULSTQF-UHFFFAOYSA-N 4-[4-[(3-chloro-4-methoxyphenyl)methylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C(C)=C(C)S2 SYHOUTHLULSTQF-UHFFFAOYSA-N 0.000 description 1
- LZAJSZOWFGXHLF-UHFFFAOYSA-N 4-[4-[(3-chloro-4-methoxyphenyl)methylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C(C)=CS2 LZAJSZOWFGXHLF-UHFFFAOYSA-N 0.000 description 1
- LMKPYTNNLBSJKC-UHFFFAOYSA-N 4-[4-[(3-chloro-4-methoxyphenyl)methylamino]-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C=C(C(F)(F)F)S2 LMKPYTNNLBSJKC-UHFFFAOYSA-N 0.000 description 1
- MIVSUDWLNLBWKO-UHFFFAOYSA-N 4-[4-[(3-chloro-4-methoxyphenyl)methylamino]-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C=C(C(F)(F)F)S2 MIVSUDWLNLBWKO-UHFFFAOYSA-N 0.000 description 1
- JXOKXHBSBDNHHY-UHFFFAOYSA-N 4-[4-[(3-chloro-4-methoxyphenyl)methylamino]-6-ethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N1=C(C=2C=CC(=CC=2)C(O)=O)N=C2SC(CC)=CC2=C1NCC1=CC=C(OC)C(Cl)=C1 JXOKXHBSBDNHHY-UHFFFAOYSA-N 0.000 description 1
- CPVCLJXBERHQBO-UHFFFAOYSA-N 4-[4-[(3-chloro-4-methoxyphenyl)methylamino]-6-ethylthieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound N1=C(C2CCC(CC2)C(O)=O)N=C2SC(CC)=CC2=C1NCC1=CC=C(OC)C(Cl)=C1 CPVCLJXBERHQBO-UHFFFAOYSA-N 0.000 description 1
- PYHUYULPDSZXGW-UHFFFAOYSA-N 4-[4-[(3-chloro-4-methoxyphenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C=C(C)S2 PYHUYULPDSZXGW-UHFFFAOYSA-N 0.000 description 1
- IFUSBSXYWLLMOE-UHFFFAOYSA-N 4-[4-[(3-nitrophenyl)methylamino]-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCC=2C=C(C=CC=2)[N+]([O-])=O)=C(C2=C(CCCC2)S2)C2=N1 IFUSBSXYWLLMOE-UHFFFAOYSA-N 0.000 description 1
- HLSISSOWCVNFNC-UHFFFAOYSA-N 4-[4-[(3-nitrophenyl)methylamino]-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCC=2C=C(C=CC=2)[N+]([O-])=O)=C(C=C(S2)C(F)(F)F)C2=N1 HLSISSOWCVNFNC-UHFFFAOYSA-N 0.000 description 1
- BVIYYUYUOZPGPY-UHFFFAOYSA-N 4-[4-[(4-fluorophenyl)methylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C=12C(C)=C(C)SC2=NC(C=2C=CC(=CC=2)C(O)=O)=NC=1NCC1=CC=C(F)C=C1 BVIYYUYUOZPGPY-UHFFFAOYSA-N 0.000 description 1
- CZYFSPOGZATSGJ-UHFFFAOYSA-N 4-[4-[(4-fluorophenyl)methylamino]-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCC=2C=CC(F)=CC=2)=C(C=C(S2)C(F)(F)F)C2=N1 CZYFSPOGZATSGJ-UHFFFAOYSA-N 0.000 description 1
- ZUWWHDPNVNPGKU-UHFFFAOYSA-N 4-[4-[(4-fluorophenyl)methylamino]-6-nitrothieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCC=2C=CC(F)=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 ZUWWHDPNVNPGKU-UHFFFAOYSA-N 0.000 description 1
- CQSJODIORHIWPC-UHFFFAOYSA-N 4-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N=1C(NCCC=2C=C3OCOC3=CC=2)=C2C(C)=C(C)SC2=NC=1C1=CC=C(C(O)=O)C=C1 CQSJODIORHIWPC-UHFFFAOYSA-N 0.000 description 1
- LNDKUCRJQRVION-UHFFFAOYSA-N 4-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-5-chloro-6-methylthieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound N=1C(NCCC=2C=C3OCOC3=CC=2)=C2C(Cl)=C(C)SC2=NC=1C1CCC(C(O)=O)CC1 LNDKUCRJQRVION-UHFFFAOYSA-N 0.000 description 1
- FBRNWFMHYIZSGM-UHFFFAOYSA-N 4-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N=1C(NCCC=2C=C3OCOC3=CC=2)=C2C(C)=CSC2=NC=1C1=CC=C(C(O)=O)C=C1 FBRNWFMHYIZSGM-UHFFFAOYSA-N 0.000 description 1
- MSJUMWJMNBRZFW-UHFFFAOYSA-N 4-[4-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N=1C(NCCC=2C=C3OCCOC3=CC=2)=C2C(C)=C(C)SC2=NC=1C1=CC=C(C(O)=O)C=C1 MSJUMWJMNBRZFW-UHFFFAOYSA-N 0.000 description 1
- WWFNLFPFVRNSFQ-UHFFFAOYSA-N 4-[4-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N=1C(NCCC=2C=C3OCCOC3=CC=2)=C2C(C)=CSC2=NC=1C1=CC=C(C(O)=O)C=C1 WWFNLFPFVRNSFQ-UHFFFAOYSA-N 0.000 description 1
- QNWQBRBEOMEKOH-UHFFFAOYSA-N 4-[4-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]-6-nitrothieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCCC=2C=C3OCCOC3=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 QNWQBRBEOMEKOH-UHFFFAOYSA-N 0.000 description 1
- RDZLCNIGGRELGX-UHFFFAOYSA-N 4-[5,6-dimethyl-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C=12C(C)=C(C)SC2=NC(C=2C=CC(=CC=2)C(O)=O)=NC=1NCCC1=CC=CC=C1 RDZLCNIGGRELGX-UHFFFAOYSA-N 0.000 description 1
- YYIFEZRNZXWVNS-UHFFFAOYSA-N 4-[5,6-dimethyl-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C=12C(C)=C(C)SC2=NC(C=2C=CC(=CC=2)C(O)=O)=NC=1NCC1=CC=CC([N+]([O-])=O)=C1 YYIFEZRNZXWVNS-UHFFFAOYSA-N 0.000 description 1
- NWPICWLBCIYONT-UHFFFAOYSA-N 4-[5-chloro-4-[(3,4-dichlorophenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C=12C(Cl)=C(C)SC2=NC(C=2C=CC(=CC=2)C(O)=O)=NC=1NCC1=CC=C(Cl)C(Cl)=C1 NWPICWLBCIYONT-UHFFFAOYSA-N 0.000 description 1
- FNMMWMYVBIIAOC-UHFFFAOYSA-N 4-[5-chloro-4-[(3,4-dimethoxyphenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C(Cl)=C(C)S2 FNMMWMYVBIIAOC-UHFFFAOYSA-N 0.000 description 1
- RLKXTFYKDIYZTG-UHFFFAOYSA-N 4-[5-chloro-4-[(3-chloro-4-methoxyphenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical class C1=C(Cl)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C(Cl)=C(C)S2 RLKXTFYKDIYZTG-UHFFFAOYSA-N 0.000 description 1
- SMUOECRBPIIKHF-UHFFFAOYSA-N 4-[5-chloro-4-[(3-chloro-4-methoxyphenyl)methylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C(Cl)=C(C)S2 SMUOECRBPIIKHF-UHFFFAOYSA-N 0.000 description 1
- UORKSCSFTPOZJA-UHFFFAOYSA-N 4-[5-chloro-4-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]-6-methylthieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N=1C(NCCC=2C=C3OCCOC3=CC=2)=C2C(Cl)=C(C)SC2=NC=1C1=CC=C(C(O)=O)C=C1 UORKSCSFTPOZJA-UHFFFAOYSA-N 0.000 description 1
- LBGZVSUUQFLRLX-UHFFFAOYSA-N 4-[5-chloro-6-methyl-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C=12C(Cl)=C(C)SC2=NC(C2CCC(CC2)C(O)=O)=NC=1NCCC1=CC=CC=C1 LBGZVSUUQFLRLX-UHFFFAOYSA-N 0.000 description 1
- APDCNTBZSOEUCC-UHFFFAOYSA-N 4-[5-chloro-6-methyl-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C=12C(Cl)=C(C)SC2=NC(C=2C=CC(=CC=2)C(O)=O)=NC=1NCC1=CC=CC([N+]([O-])=O)=C1 APDCNTBZSOEUCC-UHFFFAOYSA-N 0.000 description 1
- GTEPMRMTSVUBHX-UHFFFAOYSA-N 4-[5-methyl-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C=12C(C)=CSC2=NC(C2CCC(CC2)C(O)=O)=NC=1NCCC1=CC=CC=C1 GTEPMRMTSVUBHX-UHFFFAOYSA-N 0.000 description 1
- HEPJTEBUMZNXTO-UHFFFAOYSA-N 4-[6-chloro-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCCC=2C=CC=CC=2)=C(C=C(Cl)S2)C2=N1 HEPJTEBUMZNXTO-UHFFFAOYSA-N 0.000 description 1
- FHPPXRLIKWXKJE-UHFFFAOYSA-N 4-[6-chloro-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1CC(C(=O)O)CCC1C1=NC(NCCC=2C=CC=CC=2)=C(C=C(Cl)S2)C2=N1 FHPPXRLIKWXKJE-UHFFFAOYSA-N 0.000 description 1
- BKHCJRYOGCTBMM-UHFFFAOYSA-N 4-[6-chloro-4-[(3,4-dichlorophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCC=2C=C(Cl)C(Cl)=CC=2)=C(C=C(Cl)S2)C2=N1 BKHCJRYOGCTBMM-UHFFFAOYSA-N 0.000 description 1
- CZVRWBYZXSHBMY-UHFFFAOYSA-N 4-[6-chloro-4-[(3,4-dimethoxyphenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C=C(Cl)S2 CZVRWBYZXSHBMY-UHFFFAOYSA-N 0.000 description 1
- QOCXMDXVOJKJKO-UHFFFAOYSA-N 4-[6-chloro-4-[(3,4-dimethoxyphenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C=C(Cl)S2 QOCXMDXVOJKJKO-UHFFFAOYSA-N 0.000 description 1
- DNOKIXKZXAEVKA-UHFFFAOYSA-N 4-[6-chloro-4-[(3-chloro-4-methoxyphenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C=2C=CC(=CC=2)C(O)=O)=NC2=C1C=C(Cl)S2 DNOKIXKZXAEVKA-UHFFFAOYSA-N 0.000 description 1
- PHTHEQMCXYWMJG-UHFFFAOYSA-N 4-[6-chloro-4-[(3-chloro-4-methoxyphenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC=C1CNC1=NC(C2CCC(CC2)C(O)=O)=NC2=C1C=C(Cl)S2 PHTHEQMCXYWMJG-UHFFFAOYSA-N 0.000 description 1
- MHNSWUQKQBTGLZ-UHFFFAOYSA-N 4-[6-chloro-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCC=2C=C(C=CC=2)[N+]([O-])=O)=C(C=C(Cl)S2)C2=N1 MHNSWUQKQBTGLZ-UHFFFAOYSA-N 0.000 description 1
- SODRCSPHAHLXKH-UHFFFAOYSA-N 4-[6-ethyl-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N1=C(C=2C=CC(=CC=2)C(O)=O)N=C2SC(CC)=CC2=C1NCC1=CC=CC([N+]([O-])=O)=C1 SODRCSPHAHLXKH-UHFFFAOYSA-N 0.000 description 1
- JNSRCMJNBIJNDI-UHFFFAOYSA-N 4-[6-ethyl-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound N1=C(C2CCC(CC2)C(O)=O)N=C2SC(CC)=CC2=C1NCC1=CC=CC([N+]([O-])=O)=C1 JNSRCMJNBIJNDI-UHFFFAOYSA-N 0.000 description 1
- DHBPXPXPMVQUFP-UHFFFAOYSA-N 4-[6-methyl-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N1=C(C=2C=CC(=CC=2)C(O)=O)N=C2SC(C)=CC2=C1NCCC1=CC=CC=C1 DHBPXPXPMVQUFP-UHFFFAOYSA-N 0.000 description 1
- QYKKHTKLEFPKEN-UHFFFAOYSA-N 4-[6-methyl-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound N1=C(C2CCC(CC2)C(O)=O)N=C2SC(C)=CC2=C1NCCC1=CC=CC=C1 QYKKHTKLEFPKEN-UHFFFAOYSA-N 0.000 description 1
- WBNKSYSZUXFPBS-UHFFFAOYSA-N 4-[6-methyl-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound N1=C(C=2C=CC(=CC=2)C(O)=O)N=C2SC(C)=CC2=C1NCC1=CC=CC([N+]([O-])=O)=C1 WBNKSYSZUXFPBS-UHFFFAOYSA-N 0.000 description 1
- MYYYJCDINYWHGX-UHFFFAOYSA-N 4-[6-methyl-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound N1=C(C2CCC(CC2)C(O)=O)N=C2SC(C)=CC2=C1NCC1=CC=CC([N+]([O-])=O)=C1 MYYYJCDINYWHGX-UHFFFAOYSA-N 0.000 description 1
- CNONNLQLRVBIOG-UHFFFAOYSA-N 4-[6-nitro-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCCC=2C=CC=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 CNONNLQLRVBIOG-UHFFFAOYSA-N 0.000 description 1
- URRIUEYAKORRHF-UHFFFAOYSA-N 4-[6-nitro-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]cyclohexane-1-carboxylic acid Chemical compound C1CC(C(=O)O)CCC1C1=NC(NCCC=2C=CC=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 URRIUEYAKORRHF-UHFFFAOYSA-N 0.000 description 1
- CSMDGGSXJXQYCX-UHFFFAOYSA-N 4-[6-nitro-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NC(NCC=2C=C(C=CC=2)[N+]([O-])=O)=C(C=C(S2)[N+]([O-])=O)C2=N1 CSMDGGSXJXQYCX-UHFFFAOYSA-N 0.000 description 1
- KJZWYCAIEUYAIW-UHFFFAOYSA-N 4-cyanocyclohexane-1-carboxylic acid Chemical class OC(=O)C1CCC(C#N)CC1 KJZWYCAIEUYAIW-UHFFFAOYSA-N 0.000 description 1
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 description 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- WALSEZBDNTXSJC-UHFFFAOYSA-N COC(C1=C(C=C(C=C1)C=1N=C(C2=C(N1)SC(=C2)CCC)Cl)C)=O.NC=2SC(=CC2C(=O)OCC)CCC Chemical compound COC(C1=C(C=C(C=C1)C=1N=C(C2=C(N1)SC(=C2)CCC)Cl)C)=O.NC=2SC(=CC2C(=O)OCC)CCC WALSEZBDNTXSJC-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- CQGGSKLVDXSZQD-UHFFFAOYSA-N ClC=1C2=C(N=C(N1)C1=CC=C(C(=O)OC)C=C1)SC(=C2)CC.NC=2SC(=CC2C(=O)OCC)CC Chemical compound ClC=1C2=C(N=C(N1)C1=CC=C(C(=O)OC)C=C1)SC(=C2)CC.NC=2SC(=CC2C(=O)OCC)CC CQGGSKLVDXSZQD-UHFFFAOYSA-N 0.000 description 1
- TYQONBTVZSUVNB-UHFFFAOYSA-N ClC=1C=C(CNC=2C3=C(N=C(N2)N2CCCCC2)SC2=C3CCCC2)C=CC1OC Chemical compound ClC=1C=C(CNC=2C3=C(N=C(N2)N2CCCCC2)SC2=C3CCCC2)C=CC1OC TYQONBTVZSUVNB-UHFFFAOYSA-N 0.000 description 1
- NCSAIDFASAOXHD-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2)C(F)(F)F)NCC2=CC(=CC=C2)[N+](=O)[O-].ClC=2N=C(C1=C(N2)SC(=C1)C(F)(F)F)Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)C(F)(F)F)NCC2=CC(=CC=C2)[N+](=O)[O-].ClC=2N=C(C1=C(N2)SC(=C1)C(F)(F)F)Cl NCSAIDFASAOXHD-UHFFFAOYSA-N 0.000 description 1
- SPCUXONNCXIXOW-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2)CC)NCC2=CC(=C(C=C2)OC)Cl.ClC=2N=C(C1=C(N2)SC(=C1)CC)Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)CC)NCC2=CC(=C(C=C2)OC)Cl.ClC=2N=C(C1=C(N2)SC(=C1)CC)Cl SPCUXONNCXIXOW-UHFFFAOYSA-N 0.000 description 1
- MMQKXGLZZNAIHH-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2)CC)NCC2=CC(=C(C=C2)OC)OC.ClC=2N=C(C1=C(N2)SC(=C1)CC)Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)CC)NCC2=CC(=C(C=C2)OC)OC.ClC=2N=C(C1=C(N2)SC(=C1)CC)Cl MMQKXGLZZNAIHH-UHFFFAOYSA-N 0.000 description 1
- MVUJCWGTWLPHFM-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2)CC)NCC2=CC1=C(C=C2)OCO1.ClC=1N=C(C2=C(N1)SC(=C2)CC)Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)CC)NCC2=CC1=C(C=C2)OCO1.ClC=1N=C(C2=C(N1)SC(=C2)CC)Cl MVUJCWGTWLPHFM-UHFFFAOYSA-N 0.000 description 1
- FBKWLSKJWLUELT-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2)CC)NCC2=CC=CC=C2.ClC=2N=C(C1=C(N2)SC(=C1)CC)Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)CC)NCC2=CC=CC=C2.ClC=2N=C(C1=C(N2)SC(=C1)CC)Cl FBKWLSKJWLUELT-UHFFFAOYSA-N 0.000 description 1
- VWNJOFRVFOZJSQ-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])NCC2=CC(=C(C=C2)OC)OC.ClC=2N=C(C1=C(N2)SC(=C1)[N+](=O)[O-])Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])NCC2=CC(=C(C=C2)OC)OC.ClC=2N=C(C1=C(N2)SC(=C1)[N+](=O)[O-])Cl VWNJOFRVFOZJSQ-UHFFFAOYSA-N 0.000 description 1
- KUNLMCXZIMJHLW-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])NCC2=CC(=CC=C2)[N+](=O)[O-].ClC=2N=C(C1=C(N2)SC(=C1)[N+](=O)[O-])Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])NCC2=CC(=CC=C2)[N+](=O)[O-].ClC=2N=C(C1=C(N2)SC(=C1)[N+](=O)[O-])Cl KUNLMCXZIMJHLW-UHFFFAOYSA-N 0.000 description 1
- QEDZBLIJBUBGOH-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])NCC2=CC1=C(C=C2)OCO1.ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])NCC2=CC1=C(C=C2)OCO1.ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])Cl QEDZBLIJBUBGOH-UHFFFAOYSA-N 0.000 description 1
- ZZNRLLZUEAYVLA-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])NCC2=CC=CC=C2.ClC=2N=C(C1=C(N2)SC(=C1)[N+](=O)[O-])Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])NCC2=CC=CC=C2.ClC=2N=C(C1=C(N2)SC(=C1)[N+](=O)[O-])Cl ZZNRLLZUEAYVLA-UHFFFAOYSA-N 0.000 description 1
- OTHWYZPUEPKITM-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])NCCC2=CC1=C(C=C2)OCO1.ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])NCCC2=CC1=C(C=C2)OCO1.ClC=1N=C(C2=C(N1)SC(=C2)[N+](=O)[O-])Cl OTHWYZPUEPKITM-UHFFFAOYSA-N 0.000 description 1
- DBYPJZIZQZSHNJ-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC(=C2C)C)NCC2=CC(=CC=C2)[N+](=O)[O-].ClC=2N=C(C1=C(N2)SC(=C1C)C)Cl Chemical compound ClC=1N=C(C2=C(N1)SC(=C2C)C)NCC2=CC(=CC=C2)[N+](=O)[O-].ClC=2N=C(C1=C(N2)SC(=C1C)C)Cl DBYPJZIZQZSHNJ-UHFFFAOYSA-N 0.000 description 1
- XREFGZFWBUORLQ-UHFFFAOYSA-N ClC=1N=C(C2=C(N1)SC=C2C)NCCC2=CC1=C(C=C2)OCO1.ClC=1N=C(C2=C(N1)SC=C2C)Cl Chemical compound ClC=1N=C(C2=C(N1)SC=C2C)NCCC2=CC1=C(C=C2)OCO1.ClC=1N=C(C2=C(N1)SC=C2C)Cl XREFGZFWBUORLQ-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- QQPJHZMRCSZEDZ-UHFFFAOYSA-N FC1=CC=C(CNC=2C3=C(N=C(N2)C2=CC=C(C(=O)OC)C=C2)SC=C3C)C=C1.ClC=1C3=C(N=C(N1)C1=CC=C(C(=O)OC)C=C1)SC=C3C Chemical compound FC1=CC=C(CNC=2C3=C(N=C(N2)C2=CC=C(C(=O)OC)C=C2)SC=C3C)C=C1.ClC=1C3=C(N=C(N1)C1=CC=C(C(=O)OC)C=C1)SC=C3C QQPJHZMRCSZEDZ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- OTYRUSCCSIXCOZ-UHFFFAOYSA-N N-benzyl-2-chloro-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-amine 2,4-dichloro-6-(trifluoromethyl)thieno[2,3-d]pyrimidine Chemical compound ClC=1N=C(C2=C(N1)SC(=C2)C(F)(F)F)NCC2=CC=CC=C2.ClC=2N=C(C1=C(N2)SC(=C1)C(F)(F)F)Cl OTYRUSCCSIXCOZ-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- QKXPVOZGIGLHKI-UHFFFAOYSA-N [N+](=O)([O-])C=1C=C(CNC=2C3=C(N=C(N2)C2=CC=C(C(=O)OC)C=C2)SC=C3C)C=CC1.ClC=1C3=C(N=C(N1)C1=CC=C(C(=O)OC)C=C1)SC=C3C Chemical compound [N+](=O)([O-])C=1C=C(CNC=2C3=C(N=C(N2)C2=CC=C(C(=O)OC)C=C2)SC=C3C)C=CC1.ClC=1C3=C(N=C(N1)C1=CC=C(C(=O)OC)C=C1)SC=C3C QKXPVOZGIGLHKI-UHFFFAOYSA-N 0.000 description 1
- HPXADUAPQASOMR-UHFFFAOYSA-N [Na].CC1=CC2=C(N=C(N=C2NCC2=CC3=C(C=C2)OCO3)N3CCCCC3)S1 Chemical compound [Na].CC1=CC2=C(N=C(N=C2NCC2=CC3=C(C=C2)OCO3)N3CCCCC3)S1 HPXADUAPQASOMR-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000003975 aryl alkyl amines Chemical class 0.000 description 1
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 150000003938 benzyl alcohols Chemical class 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- WLDMECQMRVSGPT-UHFFFAOYSA-N ethyl 1-[4-(benzylamino)-5-chloro-6-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=NC(NCC=2C=CC=CC=2)=C(C(Cl)=C(C)S2)C2=N1 WLDMECQMRVSGPT-UHFFFAOYSA-N 0.000 description 1
- GLUWYJJUSFHPFE-UHFFFAOYSA-N ethyl 1-[4-(benzylamino)-5-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=NC(NCC=2C=CC=CC=2)=C(C(C)=CS2)C2=N1 GLUWYJJUSFHPFE-UHFFFAOYSA-N 0.000 description 1
- YSJKCBTYKXEBMK-UHFFFAOYSA-N ethyl 1-[4-[(3,4-dimethoxyphenyl)methylamino]-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=NC(NCC=2C=C(OC)C(OC)=CC=2)=C(C2=C(CCCC2)S2)C2=N1 YSJKCBTYKXEBMK-UHFFFAOYSA-N 0.000 description 1
- TUSGCCPHUAIEMY-UHFFFAOYSA-N ethyl 1-[4-[(3,4-dimethoxyphenyl)methylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=NC(NCC=2C=C(OC)C(OC)=CC=2)=C(C(C)=CS2)C2=N1 TUSGCCPHUAIEMY-UHFFFAOYSA-N 0.000 description 1
- VPDBVZUBHLFAGQ-UHFFFAOYSA-N ethyl 1-[6-nitro-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=NC(NCC=2C=C(C=CC=2)[N+]([O-])=O)=C(C=C(S2)[N+]([O-])=O)C2=N1 VPDBVZUBHLFAGQ-UHFFFAOYSA-N 0.000 description 1
- IBBDIRWOKRFCJB-UHFFFAOYSA-N ethyl 2-amino-4,5-dimethylthiophene-3-carboxylate methyl 4-(4-chloro-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl)benzoate Chemical compound ClC=1C2=C(N=C(N1)C1=CC=C(C(=O)OC)C=C1)SC(=C2C)C.NC=2SC(=C(C2C(=O)OCC)C)C IBBDIRWOKRFCJB-UHFFFAOYSA-N 0.000 description 1
- IERFTHZUUOYHHX-UHFFFAOYSA-N ethyl 2-amino-4-chloro-5-methylthiophene-3-carboxylate Chemical compound CCOC(=O)C1=C(N)SC(C)=C1Cl IERFTHZUUOYHHX-UHFFFAOYSA-N 0.000 description 1
- DGEIHXNYBBKRMS-UHFFFAOYSA-N ethyl 2-amino-5-chlorothiophene-3-carboxylate Chemical compound CCOC(=O)C=1C=C(Cl)SC=1N DGEIHXNYBBKRMS-UHFFFAOYSA-N 0.000 description 1
- AYBUNZGJQVYGTM-UHFFFAOYSA-N ethyl 2-amino-5-methylthiophene-3-carboxylate Chemical compound CCOC(=O)C=1C=C(C)SC=1N AYBUNZGJQVYGTM-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- XPBHWSMZTSSEJE-UHFFFAOYSA-N methyl 3-cyanobenzoate Chemical compound COC(=O)C1=CC=CC(C#N)=C1 XPBHWSMZTSSEJE-UHFFFAOYSA-N 0.000 description 1
- BKOFSDOKUKNCFH-UHFFFAOYSA-N methyl 4-(4-chloro-5-methylthieno[2,3-d]pyrimidin-2-yl)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(Cl)=C(C(C)=CS2)C2=N1 BKOFSDOKUKNCFH-UHFFFAOYSA-N 0.000 description 1
- HFOGKFPVGKOVQI-UHFFFAOYSA-N methyl 4-(4-chloro-6-nitrothieno[2,3-d]pyrimidin-2-yl)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(Cl)=C(C=C(S2)[N+]([O-])=O)C2=N1 HFOGKFPVGKOVQI-UHFFFAOYSA-N 0.000 description 1
- VILQDUKEPCKQMW-UHFFFAOYSA-N methyl 4-[4-(1,3-benzodioxol-5-ylmethylamino)-6-methylthieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCC=2C=C3OCOC3=CC=2)=C(C=C(C)S2)C2=N1 VILQDUKEPCKQMW-UHFFFAOYSA-N 0.000 description 1
- NYLYXYSPEQUNIP-UHFFFAOYSA-N methyl 4-[4-(1,3-benzodioxol-5-ylmethylamino)-6-nitrothieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCC=2C=C3OCOC3=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 NYLYXYSPEQUNIP-UHFFFAOYSA-N 0.000 description 1
- HFQHCKNLRAHJMT-UHFFFAOYSA-N methyl 4-[4-(1,3-benzodioxol-5-ylmethylamino)-6-propylthieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound N1=C2SC(CCC)=CC2=C(NCC=2C=C3OCOC3=CC=2)N=C1C1=CC=C(C(=O)OC)C=C1 HFQHCKNLRAHJMT-UHFFFAOYSA-N 0.000 description 1
- JZEZFEXPNNYVBR-UHFFFAOYSA-N methyl 4-[4-[(3,4-dichlorophenyl)methylamino]-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCC=2C=C(Cl)C(Cl)=CC=2)=C(C(C)=C(C)S2)C2=N1 JZEZFEXPNNYVBR-UHFFFAOYSA-N 0.000 description 1
- BCUNKNBYTLBYHU-UHFFFAOYSA-N methyl 4-[4-[(3,4-dichlorophenyl)methylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCC=2C=C(Cl)C(Cl)=CC=2)=C(C(C)=CS2)C2=N1 BCUNKNBYTLBYHU-UHFFFAOYSA-N 0.000 description 1
- SOBVPOWKKLLACB-UHFFFAOYSA-N methyl 4-[4-[(3,4-dimethoxyphenyl)methylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCC=2C=C(OC)C(OC)=CC=2)=C(C(C)=CS2)C2=N1 SOBVPOWKKLLACB-UHFFFAOYSA-N 0.000 description 1
- XALMCRNVAQWUDJ-UHFFFAOYSA-N methyl 4-[4-[2-(1,3-benzodioxol-5-yl)ethylamino]-6-nitrothieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCCC=2C=C3OCOC3=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 XALMCRNVAQWUDJ-UHFFFAOYSA-N 0.000 description 1
- XKIUNULXYGVQPD-UHFFFAOYSA-N methyl 4-[4-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]-5-methylthieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCCC=2C=C3OCCOC3=CC=2)=C(C(C)=CS2)C2=N1 XKIUNULXYGVQPD-UHFFFAOYSA-N 0.000 description 1
- XQPICLBTFWZDBB-UHFFFAOYSA-N methyl 4-[4-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]-6-ethylthieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound N1=C2SC(CC)=CC2=C(NCCC=2C=C3OCCOC3=CC=2)N=C1C1=CC=C(C(=O)OC)C=C1 XQPICLBTFWZDBB-UHFFFAOYSA-N 0.000 description 1
- QFKIFLWFQJIYPR-UHFFFAOYSA-N methyl 4-[4-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]-6-nitrothieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCCC=2C=C3OCCOC3=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 QFKIFLWFQJIYPR-UHFFFAOYSA-N 0.000 description 1
- SLCCAHSXUVLGGV-UHFFFAOYSA-N methyl 4-[5-chloro-6-methyl-4-[(3-nitrophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCC=2C=C(C=CC=2)[N+]([O-])=O)=C(C(Cl)=C(C)S2)C2=N1 SLCCAHSXUVLGGV-UHFFFAOYSA-N 0.000 description 1
- LCVAKVMQIQHHKZ-UHFFFAOYSA-N methyl 4-[6-chloro-4-[(3,4-dichlorophenyl)methylamino]thieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCC=2C=C(Cl)C(Cl)=CC=2)=C(C=C(Cl)S2)C2=N1 LCVAKVMQIQHHKZ-UHFFFAOYSA-N 0.000 description 1
- NSBIGCPGKJARHT-UHFFFAOYSA-N methyl 4-[6-ethyl-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound N1=C(C=2C=CC(=CC=2)C(=O)OC)N=C2SC(CC)=CC2=C1NCCC1=CC=CC=C1 NSBIGCPGKJARHT-UHFFFAOYSA-N 0.000 description 1
- JOACXHSGPQXNQD-UHFFFAOYSA-N methyl 4-[6-nitro-4-(2-phenylethylamino)thieno[2,3-d]pyrimidin-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC(NCCC=2C=CC=CC=2)=C(C=C(S2)[N+]([O-])=O)C2=N1 JOACXHSGPQXNQD-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- QDACCFRDPVSPEC-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-2,5-dichloro-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C2OCOC2=CC(CNC=2N=C(Cl)N=C3SC(=C(C3=2)Cl)C)=C1 QDACCFRDPVSPEC-UHFFFAOYSA-N 0.000 description 1
- SFKXABRBTMDYBC-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-2-chloro-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-amine Chemical compound C1CCCC2=C1C1=C(NCC=3C=C4OCOC4=CC=3)N=C(Cl)N=C1S2 SFKXABRBTMDYBC-UHFFFAOYSA-N 0.000 description 1
- GMOJSYQEVFUKKP-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-2-chloro-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-amine;2,4-dichloro-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine Chemical compound C1CCCC2=C1C1=C(Cl)N=C(Cl)N=C1S2.C1CCCC2=C1C1=C(NCC=3C=C4OCOC4=CC=3)N=C(Cl)N=C1S2 GMOJSYQEVFUKKP-UHFFFAOYSA-N 0.000 description 1
- UNJUEEAMOUUCRY-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-2-chloro-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C2OCOC2=CC(CNC=2N=C(Cl)N=C3SC(=C(C3=2)C)C)=C1 UNJUEEAMOUUCRY-UHFFFAOYSA-N 0.000 description 1
- IWRLJHBMZUZYLL-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-2-chloro-6-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C2OCOC2=CC(CNC2=C3C=C(SC3=NC(Cl)=N2)C(F)(F)F)=C1 IWRLJHBMZUZYLL-UHFFFAOYSA-N 0.000 description 1
- CHICRLRXAMHNRI-UHFFFAOYSA-N n-[2-(1,3-benzodioxol-5-yl)ethyl]-2,5-dichloro-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C2OCOC2=CC(CCNC=2N=C(Cl)N=C3SC(=C(C3=2)Cl)C)=C1 CHICRLRXAMHNRI-UHFFFAOYSA-N 0.000 description 1
- LQBJBUYNQLVPLN-UHFFFAOYSA-N n-[2-(1,3-benzodioxol-5-yl)ethyl]-2,6-dichlorothieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C2OCOC2=CC(CCNC2=C3C=C(SC3=NC(Cl)=N2)Cl)=C1 LQBJBUYNQLVPLN-UHFFFAOYSA-N 0.000 description 1
- FFKRMHLAQVBFNG-UHFFFAOYSA-N n-[2-(1,3-benzodioxol-5-yl)ethyl]-2-chloro-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C2OCOC2=CC(CCNC=2N=C(Cl)N=C3SC(=C(C3=2)C)C)=C1 FFKRMHLAQVBFNG-UHFFFAOYSA-N 0.000 description 1
- QHMRPBQERXRLLG-UHFFFAOYSA-N n-[2-(1,3-benzodioxol-5-yl)ethyl]-2-chloro-6-ethylthieno[2,3-d]pyrimidin-4-amine Chemical compound C1=C2OCOC2=CC(CCNC2=C3C=C(SC3=NC(Cl)=N2)CC)=C1 QHMRPBQERXRLLG-UHFFFAOYSA-N 0.000 description 1
- HOJXREDTFZPKNY-UHFFFAOYSA-N n-benzyl-2,5-dichloro-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C=12C(Cl)=C(C)SC2=NC(Cl)=NC=1NCC1=CC=CC=C1 HOJXREDTFZPKNY-UHFFFAOYSA-N 0.000 description 1
- SIWGEPFTQFDTJA-UHFFFAOYSA-N n-benzyl-2,6-dichlorothieno[2,3-d]pyrimidin-4-amine Chemical compound N1=C(Cl)N=C2SC(Cl)=CC2=C1NCC1=CC=CC=C1 SIWGEPFTQFDTJA-UHFFFAOYSA-N 0.000 description 1
- PZCPVGDWLWOGCJ-UHFFFAOYSA-N n-benzyl-2-chloro-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine;2,4-dichloro-5,6-dimethylthieno[2,3-d]pyrimidine Chemical compound ClC1=NC(Cl)=C2C(C)=C(C)SC2=N1.C=12C(C)=C(C)SC2=NC(Cl)=NC=1NCC1=CC=CC=C1 PZCPVGDWLWOGCJ-UHFFFAOYSA-N 0.000 description 1
- FBBHCKGTDRVOCN-UHFFFAOYSA-N n-benzyl-2-chloro-6-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound N1=C(Cl)N=C2SC(C)=CC2=C1NCC1=CC=CC=C1 FBBHCKGTDRVOCN-UHFFFAOYSA-N 0.000 description 1
- PIIHPBHYDCOPKZ-UHFFFAOYSA-N n-fluoro-n-methylmethanamine Chemical compound CN(C)F PIIHPBHYDCOPKZ-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- YZMHQCWXYHARLS-UHFFFAOYSA-N naphthalene-1,2-disulfonic acid Chemical compound C1=CC=CC2=C(S(O)(=O)=O)C(S(=O)(=O)O)=CC=C21 YZMHQCWXYHARLS-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 230000018791 negative regulation of catalytic activity Effects 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229940117803 phenethylamine Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- DOTPSQVYOBAWPQ-UHFFFAOYSA-N pyrazolo[4,3-d]pyrimidin-3-one Chemical class N1=CN=C2C(=O)N=NC2=C1 DOTPSQVYOBAWPQ-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical class S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- 150000003577 thiophenes Chemical class 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19644228A DE19644228A1 (de) | 1996-10-24 | 1996-10-24 | Thienopyrimidine |
| PCT/EP1997/005530 WO1998017668A1 (de) | 1996-10-24 | 1997-10-08 | Thienopyrimidine mit pde v inhibierender wirkung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK50299A3 SK50299A3 (en) | 2000-03-13 |
| SK284979B6 true SK284979B6 (sk) | 2006-03-02 |
Family
ID=7809880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK502-99A SK284979B6 (sk) | 1996-10-24 | 1997-10-08 | Derivát tienopyrimidínu, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6130223A (cs) |
| EP (1) | EP0934321B1 (cs) |
| JP (1) | JP2001502342A (cs) |
| KR (1) | KR100488429B1 (cs) |
| CN (1) | CN1105116C (cs) |
| AR (1) | AR008504A1 (cs) |
| AT (1) | ATE246689T1 (cs) |
| AU (1) | AU726639B2 (cs) |
| BR (1) | BR9712652A (cs) |
| CA (1) | CA2269815C (cs) |
| CZ (1) | CZ294027B6 (cs) |
| DE (2) | DE19644228A1 (cs) |
| DK (1) | DK0934321T3 (cs) |
| ES (1) | ES2201275T3 (cs) |
| HU (1) | HUP9904680A3 (cs) |
| NO (1) | NO991951L (cs) |
| PL (1) | PL192163B1 (cs) |
| PT (1) | PT934321E (cs) |
| RU (1) | RU2197492C2 (cs) |
| SK (1) | SK284979B6 (cs) |
| TW (1) | TW457242B (cs) |
| WO (1) | WO1998017668A1 (cs) |
| ZA (1) | ZA979516B (cs) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331543B1 (en) | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| DE19752952A1 (de) | 1997-11-28 | 1999-06-02 | Merck Patent Gmbh | Thienopyrimidine |
| US6410584B1 (en) | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
| US6248308B1 (en) * | 1998-04-14 | 2001-06-19 | Sepracor Inc. | Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| DE19819023A1 (de) | 1998-04-29 | 1999-11-04 | Merck Patent Gmbh | Thienopyrimidine |
| US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
| US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
| US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
| US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
| US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
| US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
| US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
| US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
| WO2000059912A1 (en) * | 1999-03-30 | 2000-10-12 | Nippon Soda Co., Ltd. | Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
| DE19928146A1 (de) * | 1999-06-19 | 2000-12-21 | Merck Patent Gmbh | Thienopyrimidine |
| DE19942474A1 (de) * | 1999-09-06 | 2001-03-15 | Merck Patent Gmbh | Pyrazolo[4,3-d]pyrimidine |
| DE19943815A1 (de) * | 1999-09-14 | 2001-03-15 | Merck Patent Gmbh | Verwendung von Thienopyrimidinen |
| DE19944604A1 (de) * | 1999-09-17 | 2001-03-22 | Merck Patent Gmbh | Aminderivate |
| DE10001021A1 (de) * | 2000-01-13 | 2001-07-19 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
| DE10031584A1 (de) | 2000-06-29 | 2002-01-10 | Merck Patent Gmbh | 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine |
| DE10031585A1 (de) | 2000-06-29 | 2002-01-10 | Merck Patent Gmbh | 2-Aminoalkyl-thieno[2,3-d]pyrimidine |
| DE10042997A1 (de) * | 2000-09-01 | 2002-03-14 | Merck Patent Gmbh | Thienopyrimidine |
| KR20030034232A (ko) * | 2000-09-29 | 2003-05-01 | 닛뽕소다 가부시키가이샤 | 티에노피리미딘 화합물 및 그 염 및 제조방법 |
| DE10064994A1 (de) * | 2000-12-23 | 2002-07-04 | Merck Patent Gmbh | Sulfamidothienopyrimidine |
| DE10103647A1 (de) * | 2001-01-27 | 2002-08-01 | Merck Patent Gmbh | Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates |
| EP1355649A2 (de) * | 2001-01-31 | 2003-10-29 | MERCK PATENT GmbH | Pharmazeutische formulierung enthaltend pyrazolo 4,3-d]pyrimidine und nitrate oder thienopyrimidine und nitrate |
| KR20030071880A (ko) * | 2001-02-02 | 2003-09-06 | 메르크 파텐트 게엠베하 | 피라졸로[4,3-d]피리미딘과 엔도델린 수용체 길항제또는 티에노피리미딘과 엔도델린 수용체 길항제를포함하여 이루어지는 약제학적 조성물 |
| EP1401840A4 (en) * | 2001-04-30 | 2007-05-16 | Bayer Corp | NEW 4-AMINO-5,6-SUBSTITUTED THIOPHENO 2,3 D | PYRIMIDINE |
| DE10148883A1 (de) | 2001-10-04 | 2003-04-10 | Merck Patent Gmbh | Pyrimidinderivate |
| WO2003035653A1 (en) * | 2001-10-26 | 2003-05-01 | Nippon Soda Co.,Ltd. | Pyridothienopyrimidine compound and salt thereof |
| US7893101B2 (en) | 2002-03-20 | 2011-02-22 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
| US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| US7276529B2 (en) | 2002-03-20 | 2007-10-02 | Celgene Corporation | Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| US7208516B2 (en) | 2002-03-20 | 2007-04-24 | Celgene Corporation | Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| DE10224462A1 (de) * | 2002-06-03 | 2003-12-11 | Bayer Ag | Verwendung von cGMP stimulierenden Verbindungen |
| AR044743A1 (es) * | 2002-09-26 | 2005-10-05 | Nihon Nohyaku Co Ltd | Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos, |
| JP2004137270A (ja) * | 2002-09-26 | 2004-05-13 | Nippon Nohyaku Co Ltd | 新規除草剤、その使用方法、新規置換チエノピリミジン誘導体及びその中間体並びにそれらの製造方法 |
| ES2217956B1 (es) * | 2003-01-23 | 2006-04-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de 4-aminotieno(2,3-d)pirimidin-6-carbonitrilo. |
| OA13050A (en) | 2003-04-29 | 2006-11-10 | Pfizer Ltd | 5,7-diaminopyrazolo [4,3-D] pyrimidines useful in the treatment of hypertension. |
| DE10351436A1 (de) * | 2003-11-04 | 2005-06-09 | Merck Patent Gmbh | Verwendung von Thienopyrimidinen |
| GB0327323D0 (en) * | 2003-11-24 | 2003-12-31 | Pfizer Ltd | Novel pharmaceuticals |
| US7572799B2 (en) | 2003-11-24 | 2009-08-11 | Pfizer Inc | Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| CA2562251C (en) | 2004-04-07 | 2009-04-28 | Pfizer Inc. | Pyrazolo'4,3-d pyrimidines |
| GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| ES2259892B1 (es) * | 2004-11-30 | 2007-11-01 | Laboratorios Almirall S.A. | Nuevos derivados de piridotienopirimidina. |
| ES2259891B1 (es) * | 2004-11-30 | 2007-11-01 | Laboratorios Almirall S.A. | Nuevos derivados de piridotienopirimidina. |
| US8506934B2 (en) | 2005-04-29 | 2013-08-13 | Robert I. Henkin | Methods for detection of biological substances |
| CN101198614B (zh) * | 2005-06-14 | 2011-07-06 | Aska制药株式会社 | 噻吩并嘧啶衍生物 |
| US20070213305A1 (en) * | 2005-11-02 | 2007-09-13 | Cytovia, Inc. | N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| WO2007056215A2 (en) * | 2005-11-02 | 2007-05-18 | Cytovia, Inc. | N-aryl-thienopyrimidin-4-amines and the use thereof |
| US20070099941A1 (en) * | 2005-11-02 | 2007-05-03 | Cytovia, Inc. | N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| EP1956906A4 (en) | 2005-11-09 | 2009-12-30 | Combinatorx Inc | METHODS, COMPOSITIONS AND KITS FOR THE TREATMENT OF PATHOLOGIES |
| US20090182140A1 (en) * | 2005-12-02 | 2009-07-16 | Mitsubishi Tanabe Pharma Corporation | Alicyclic Heterocyclic Compound |
| AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| US8293489B2 (en) | 2007-01-31 | 2012-10-23 | Henkin Robert I | Methods for detection of biological substances |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| HRP20110278T1 (hr) | 2007-09-14 | 2011-05-31 | Ortho-Mcneil-Janssen Pharmaceuticals | 1',3'-disupstituirani-4-fenil,3,4,5,6-tetrahidro-2h,1'h[1,4']bipiridinil-2'-oni |
| NZ584152A (en) | 2007-09-14 | 2011-11-25 | Ortho Mcneil Janssen Pharm | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| KR20100075930A (ko) * | 2007-10-19 | 2010-07-05 | 베링거 인겔하임 인터내셔날 게엠베하 | 헤테로사이클-치환된 피페라지노-디하이드로티에노피리미딘 |
| US8580801B2 (en) | 2008-07-23 | 2013-11-12 | Robert I. Henkin | Phosphodiesterase inhibitor treatment |
| JP5547194B2 (ja) | 2008-09-02 | 2014-07-09 | ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 代謝型グルタミン酸受容体の調節因子としての3−アザビシクロ[3.1.0]ヘキシル誘導体 |
| CN102232074B (zh) | 2008-11-28 | 2014-12-03 | 奥梅-杨森制药有限公司 | 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物 |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| CA2760259C (en) | 2009-05-12 | 2018-05-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| CN102439008B (zh) | 2009-05-12 | 2015-04-29 | 杨森制药有限公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途 |
| KR101147550B1 (ko) * | 2009-10-22 | 2012-05-17 | 한국과학기술연구원 | 단백질 키나아제 저해활성을 가지는 2,7-치환된 티에노[3,2-d]피리미딘 화합물 |
| SG183304A1 (en) * | 2010-02-17 | 2012-09-27 | Takeda Pharmaceutical | Heterocyclic compound |
| CN103261195B (zh) | 2010-11-08 | 2015-09-02 | 杨森制药公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| CA2814996C (en) | 2010-11-08 | 2019-10-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| CA2815002C (en) | 2010-11-08 | 2019-10-22 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| MX2014000648A (es) | 2011-07-19 | 2014-09-25 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos y sus usos. |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| EP2903619B1 (en) | 2012-10-05 | 2019-06-05 | Robert I. Henkin | Phosphodiesterase inhibitors for treating taste and smell disorders |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| KR20200036063A (ko) | 2014-01-21 | 2020-04-06 | 얀센 파마슈티카 엔.브이. | 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도 |
| EP3096790B1 (en) | 2014-01-21 | 2019-07-10 | Janssen Pharmaceutica, N.V. | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| CN106233141B (zh) | 2014-02-18 | 2018-08-21 | 罗伯特·I·汉金 | 用于诊断和治疗味觉或嗅觉的损失和/或失真的方法和组合物 |
| EP3157520B1 (en) | 2014-06-23 | 2019-09-04 | Celgene Corporation | Apremilast for the treatment of a liver disease or a liver function abnormality |
| EP3394056B1 (en) | 2015-12-22 | 2021-04-14 | Shy Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
| CN108341830B (zh) | 2017-01-22 | 2021-03-02 | 广东东阳光药业有限公司 | 噻吩并嘧啶衍生物及其在药物中的应用 |
| MX2019014875A (es) * | 2017-06-21 | 2021-01-29 | SHY Therapeutics LLC | Compuestos que interaccionan con la superfamilia ras para el tratamiento de cancer, enfermedades inflamatorias, rasopatias y enfermedad fibrotica. |
| US12391705B2 (en) | 2018-12-19 | 2025-08-19 | Shy Therapeutics, Llc | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| AU2019452636B2 (en) | 2019-07-02 | 2025-10-16 | Sunshine Lake Pharma Co., Ltd. | Thienopyrimidine derivatives having stereo configurations and use thereof in medicine |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196207A (en) * | 1977-05-23 | 1980-04-01 | Ici Australia Limited | Process for controlling eradicating or preventing infestations of animals by Ixodid ticks |
| US4666908A (en) * | 1985-04-05 | 1987-05-19 | Warner-Lambert Company | 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use |
| US5075310A (en) * | 1988-07-01 | 1991-12-24 | Smith Kline & French Laboratories, Ltd. | Pyrimidone derivatives as bronchodilators |
| PT100905A (pt) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
| JP2657760B2 (ja) * | 1992-07-15 | 1997-09-24 | 小野薬品工業株式会社 | 4−アミノキナゾリン誘導体およびそれを含有する医薬品 |
| PH31122A (en) * | 1993-03-31 | 1998-02-23 | Eisai Co Ltd | Nitrogen-containing fused-heterocycle compounds. |
| AU677842B2 (en) * | 1993-04-06 | 1997-05-08 | Abbvie Inc. | Tetracyclic compounds as dopamine agonists |
| EP0640599B1 (en) * | 1993-08-26 | 1998-03-04 | Ono Pharmaceutical Co., Ltd. | 4-Aminopyrimidine derivatives |
| IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| US5869486A (en) * | 1995-02-24 | 1999-02-09 | Ono Pharmaceutical Co., Ltd. | Fused pyrimidines and pyriazines as pharmaceutical compounds |
-
1996
- 1996-10-24 DE DE19644228A patent/DE19644228A1/de not_active Withdrawn
-
1997
- 1997-10-06 TW TW086114590A patent/TW457242B/zh not_active IP Right Cessation
- 1997-10-08 US US09/297,186 patent/US6130223A/en not_active Expired - Fee Related
- 1997-10-08 AT AT97912139T patent/ATE246689T1/de not_active IP Right Cessation
- 1997-10-08 CZ CZ19991422A patent/CZ294027B6/cs not_active IP Right Cessation
- 1997-10-08 DE DE59710547T patent/DE59710547D1/de not_active Expired - Lifetime
- 1997-10-08 DK DK97912139T patent/DK0934321T3/da active
- 1997-10-08 PT PT97912139T patent/PT934321E/pt unknown
- 1997-10-08 CN CN97180749A patent/CN1105116C/zh not_active Expired - Fee Related
- 1997-10-08 CA CA002269815A patent/CA2269815C/en not_active Expired - Fee Related
- 1997-10-08 BR BR9712652-7A patent/BR9712652A/pt not_active Application Discontinuation
- 1997-10-08 EP EP97912139A patent/EP0934321B1/de not_active Expired - Lifetime
- 1997-10-08 SK SK502-99A patent/SK284979B6/sk unknown
- 1997-10-08 WO PCT/EP1997/005530 patent/WO1998017668A1/de not_active Ceased
- 1997-10-08 RU RU99110944/04A patent/RU2197492C2/ru not_active IP Right Cessation
- 1997-10-08 ES ES97912139T patent/ES2201275T3/es not_active Expired - Lifetime
- 1997-10-08 AU AU49450/97A patent/AU726639B2/en not_active Ceased
- 1997-10-08 PL PL332970A patent/PL192163B1/pl not_active IP Right Cessation
- 1997-10-08 HU HU9904680A patent/HUP9904680A3/hu unknown
- 1997-10-08 JP JP10518895A patent/JP2001502342A/ja active Pending
- 1997-10-08 KR KR10-1999-7003580A patent/KR100488429B1/ko not_active Expired - Fee Related
- 1997-10-23 ZA ZA9709516A patent/ZA979516B/xx unknown
- 1997-10-24 AR ARP970104923A patent/AR008504A1/es not_active Application Discontinuation
-
1999
- 1999-04-23 NO NO991951A patent/NO991951L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100488429B1 (ko) | 2005-05-10 |
| DK0934321T3 (da) | 2003-11-03 |
| CN1105116C (zh) | 2003-04-09 |
| JP2001502342A (ja) | 2001-02-20 |
| HK1024484A1 (en) | 2000-10-13 |
| SK50299A3 (en) | 2000-03-13 |
| BR9712652A (pt) | 1999-10-26 |
| HUP9904680A3 (en) | 2001-11-28 |
| TW457242B (en) | 2001-10-01 |
| CA2269815A1 (en) | 1998-04-30 |
| CZ142299A3 (cs) | 1999-07-14 |
| EP0934321B1 (de) | 2003-08-06 |
| ES2201275T3 (es) | 2004-03-16 |
| WO1998017668A1 (de) | 1998-04-30 |
| AR008504A1 (es) | 2000-01-19 |
| CZ294027B6 (cs) | 2004-09-15 |
| RU2197492C2 (ru) | 2003-01-27 |
| ATE246689T1 (de) | 2003-08-15 |
| CA2269815C (en) | 2007-09-25 |
| AU726639B2 (en) | 2000-11-16 |
| US6130223A (en) | 2000-10-10 |
| EP0934321A1 (de) | 1999-08-11 |
| NO991951L (no) | 1999-06-17 |
| CN1240450A (zh) | 2000-01-05 |
| DE19644228A1 (de) | 1998-04-30 |
| AU4945097A (en) | 1998-05-15 |
| NO991951D0 (no) | 1999-04-23 |
| PT934321E (pt) | 2003-12-31 |
| KR20000052772A (ko) | 2000-08-25 |
| DE59710547D1 (de) | 2003-09-11 |
| ZA979516B (en) | 1998-05-12 |
| HUP9904680A2 (hu) | 2000-05-28 |
| PL332970A1 (en) | 1999-10-25 |
| PL192163B1 (pl) | 2006-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK284979B6 (sk) | Derivát tienopyrimidínu, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
| KR100502271B1 (ko) | 티에노피리미딘 | |
| US6420368B1 (en) | Thienopyrimidines | |
| DE19819023A1 (de) | Thienopyrimidine | |
| SK17632002A3 (sk) | Derivát 5-aminoalkylpyrazolo[4,4-d]pyrimidínu, spôsob jeho prípravy, jeho použitie a liečivo, ktoré ho obsahuje | |
| SK10762003A3 (sk) | Farmaceutický prostriedok obsahujúci parazolo-[4,3-d]pyrimidíny a nitráty alebo tienopyrimidíny a nitráty | |
| EP1351962B1 (de) | Thienopyrimidine | |
| CZ20024070A3 (cs) | Derivát 2-aminoalkylthieno[2,3-d]pyrimidinu, způsob jeho přípravy, jeho použití a léčivo, které ho obsahuje | |
| WO2001021620A2 (de) | Aminderivate von benzo-4,5-thieno-2,3-d-pyrimidinen | |
| MXPA99003833A (en) | Thienopyrimidine with phosphodiesterase v inhibiting effect | |
| MXPA99001387A (en) | Thienopyrimidines |